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St. Catherine region is located in Sinai Peninsula of Egypt, where two continents, Asia and 
Africa, are geographically connected. The area has a characteristic floristic diversity, within 
which a number of endemic plant species grow. So far, the biological and/or chemical analy-
sis of many of these endemic species has not thoroughly reported. Accordingly, this study 
aimed at biological and chemical investigation of two plant species, P. boveana and A. pu-
bescens, growing endemically in St. Catherine.  
The bacterial/ChE inhibition activities of P. boveana (leaf) and P. veris (flower) extracts 
were evaluated via HPTLC-EDA hyphenation. Identification of the active metabolites was 
based on the HPTLC-MS and NMR analysis. The active metabolites were identified as lino-
leic and linolenic acids (in P. veris) and unsubstituted flavone, 2'-methoxy-, 2'-hydroxy-, and 
5,6,2',6'-tetramethoxyflavone (in P. boveana).  
In A. pubescens, the HPTLC-AChE inhibition activity screening of the 80% alcoholic extract 
of the plant led to determination of three active metabolites. Their characterization was based 
on the analysis of the collected mass and NMR data. Two of these metabolites were defined 
as newly isolated natural compounds; were elucidated to be 6-O-, 6'-O-di-trans-cinnamoyl-
antirrhinoside and 5-O-, 6-O-difoliamenthoyl-antirrhinoside, while the previously known 
compound was determined as 6-O-foliamenthoyl-(6ꞌ-O-cinnamoyl)-antirrhinoside. 
In the third part of the study, a new HPTLC-β-glucuronidase inhibition assay was developed. 
The method was optimized and also verified using two botanical materials. The new hyphen-
ation allowed, for the first time, the direct determination of the β-glucuronidase inhibitors 
present in complex mixtures. 
The fourth part of the study reported the HPLC-HRMS (/MS) analysis of the 80% alcoholic 
extract of P. boveana. A total of 25 metabolites have been tentatively identified as flavonoid 
compounds. The metabolites included, glycoconjugated flavonoids and flavonoid aglycones.  
Overall conclusion, the study supported the herbal-evidenced based medicine through estab-
lishment of important bioactivities to some plant species. It also confirmed the potential of 
chromatography/biological activity/chemical analysis hyphenation in evaluation of biological 




Die Region St. Katharina liegt auf der ägyptischen Sinai-Halbinsel, wo zwei Kontinente, 
Asien und Afrika, geographisch miteinander verbunden sind. Das Gebiet besitzt eine charak-
teristische floristische Vielfalt, in der eine Reihe von endemischen Pflanzenarten wachsen. 
Bisher wurde nur wenig über die biologische und/oder chemische Analyse vieler dieser Arten 
berichtet. Die vorhandene Studie zielt auf die biologische und chemische Untersuchung von 
zwei Pflanzenarten, die endemisch in der Region St. Katharina wachsen, P. boveana und A. 
pubescens.   
Die antibakterielle Aktivität sowie die Inhibierung der ChE von Extrakten der P. boveana 
(Blatt) sowie P. veris (Blüte) wurde durch HPTLC-EDA Kupplung ausgewertet. Die Identi-
fizierung der aktiven Metaboliten basierte auf Untersuchungsmethoden wie HPTLC-MS und 
NMR-Analyse. Die aktiven Metaboliten wurden als Linol- und Linolensäure (in P. veris) 
sowie nicht substituiertes Flavon, 2'-Methoxy-, 2'-Hydroxy- und 5,6,2',6'-
Tetramethoxyflavon (in P. boveana) identifiziert. Das HPTLC-AChE Assay (Enzyminhibier-
ung) des 80%igen alkoholischen Extrakts der Pflanze A. pubescens führte zur Bestimmung 
von drei aktiven Metaboliten. Ihre Charakterisierung basiert auf der Analyse der gesammel-
ten Massen- und NMR-Daten. Zwei dieser Metaboliten wurden als neu isolierte Naturstoffe 
definiert. Sie wurden mit 6-O-, 6'-O-Di-trans-Cinnamoyl-antirrhinosid und 5-O-, 6-O-
Difoliamenthoyl-antirrhinosid identifiziert, während die zuvor bekannte Verbindung als 6-O-
Foliamenthoyl-(6ꞌ-O-cinnamoyl)-antirrhinosid bestimmt wurde. Im dritten Teil der Studie 
wurde ein neuartiger HPTLC-β-Glucuronidase-Inhibitor-Assay entwickelt. Die Methode 
wurde optimiert und mit zwei Materialien botanischer Art verifiziert. Die neu etablierte 
Trennung ermöglichte erstmals die direkte Bestimmung der in komplexen Gemischen 
vorhandenen β-Glukuronidase-Inhibitoren. Der vierte Teil der Studie befasst sich mit der 
HPLC-HRMS(/MS) Analyse des 80%igen alkoholischen Extrakts von P. boveana. Insgesamt 
25 Metaboliten wurden vorläufig als Flavonoidverbindungen identifiziert. Zu den Metabo-
liten gehören glykokonjugierte Flavonoide und Flavonoid-Aglykone.  
Zusammenfassend die hier vorgestellten Methoden leisten einen wichtigen Beitrag zur Phy-
tomedizin, da in den untersuchten Pflanzen neue Bioaktivitäten beschrieben werden konnten. 
An mehreren Beispielen konnte gezeigt werden, dass eine Kombination aus Chromatographie 
und Aktivitätstestung dazu geeignet ist, biologische Materialien, die nur in geringen Mengen 










1.1. General  
 
Nature is a major source of numerous valuable ingredients. A broad range of biological 
systems including plants, microbes, and marine organisms, have supplied humans with many 
important drugs. Even though some modern means of drug discovery have been well-
developed, e.g. chemical synthesis and computer-based molecular modeling, still multiple 
aspects are remained questionable. For examples, the encountered undesirable side actions of 
the synthetic molecules, the complexity and cost effectiveness of the production process, and 
the affordability to the world population (Tyler 1999; Rates 2001; Veeresham 2012). Togeth-
er, these challenges have reignited the interest of many researchers to reconsider the nature as 
a comparably safe, easy to access, and sustainable source of drugs. Over the time frame 
1981-2010, approximately 48.6% of the approved drugs by FDA or similar organizations 
were natural products or derivatives of natural products; the anti-infective area was found 
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mainly dependent on natural products (Newman and Cragg 2012, 2016). Representative ex-
amples of naturally occurring compounds with approved medicinal uses are presented in Ta-
ble 1. 
 
Table 1:  Selected medicinal drugs from natural sources (Guerram et al. 2012; Martins et al. 2014; 
Ganeshpurkar and Saluja 2017). 
 










• Antioxidant  
















































1.2. Plants as a source of drugs 
 
Plants represent an important source of bioactive agents. Reliance on plants as a primary 
health caretaker dates back to ancient generations. Past civilizations developed several cura-
tives from botanical sources; many of them are still in use until now. Prominent examples are 
the ancient Egyptians (2900 BC), who used plants as remedies and their preserved records is 
“Ebers Papyrus” from about 1550 BC. Also, the traditional Chinese medicine has historical 
applications with first report dates back to 1100 BC and the Indian Ayurvedic system dates 
from before 1000 BC (Cragg and Newman 2013). Approximately, 320000 plant species in 
our planet (Sneader 2005). It was only at the beginning of the 19th century until the notion of 
metabolites isolation has been evolved, which initially presented by the German apothecary 
assistant Friedrich Sertürner who succeeded to isolate the first natural compound, morphine, 
from opium (Atanasov et al. 2015). Sequentially in the following decades, a progress in the 
purification of plant-based natural products has been significantly rocketed, which led to the 
use of the concentrated effective fractions/substances instead of the whole herbal products 
that could contain many irrelevant constituents. Currently, the ethnopharmacological infor-
mation for many plants is better available, facilitating the process of targeted drug discovery. 
About 80% of the 122 plant-derived drugs that reported for use globally were from plants 
having ethnomedical use of similar or closely related indications as the respective isolated 
candidates are prescribed (Atanasov et al. 2015). A trend analysis on the Pubmed database 
(Fig. 1) showed a significant increase in the number of researches concerned with plant natu-
ral products as indicated by the number of publications during the period 1992-2012. Analy-
sis was generated (March 2019) using the webtool MEDSUM (http://webtools.mf.uni-
lj.si/public/medsum.html). 
 
Fig. 1. Line graph shows the Pubmed  data-
base analysis using "plant natural 









1.3. Plant secondary metabolites 
 
Plants are splendid machines, capable of synthesizing many secondary metabolites with 
varied chemical structures. Full understanding of the beneficial roles of the SMs in plants is 
always an active area of research. However, several reports have evidenced the functions of 
SMs as mainly related to their defense actions toward the adverse effects of biotic and/or abi-
otic stresses (Zaynab et al. 2018; Takshak and Agrawal 2019). Furthermore, these com-
pounds possess a physiological importance, like attracting pollinators (Stevenson et al. 2017; 
Wink 2018) and supplying key components of plant tissue structure (Liu 2018). 
Chemotaxonomic classification of SMs relies primarily on their chemical structures. Three 
major categories (phenolics, terpenoids, and nitrogen-containing compounds) have been rec-
ognized mostly in the scientific reports; these categories cover almost all of these chemicals 
(Kabera et al. 2014).  
Phenolic compounds comprise a large group of SMs occurring abundantly in many 
plants. Their structures widely differ from considerably simple molecules containing only 
one benzene ring to quite large polymerized compounds (Lin et al. 2016). Due to this broad 
structures variation, plant phenolics are usually undergo further classification into several di-
visions (Tsimogiannis and Oreopoulou 2019). Phenolic metabolites include, benzoic acid de-
rivatives, phenylpropanoids, lignans and lignins, coumarins, aromatic polyketides, flavo-
noids, and stilbens. Representative examples of the major phenolic classes are shown in Fig. 
2. 
Typically, phenolics like flavonoids are biosynthesized in plants via shikimate pathway; this 
pathway is also shared by other SMs, e.g. alkaloids. The biosynthetic pathway depends on 
two other proceeding pathways, glycolytic and pentose phosphate pathways, which provide 
phosphoenol pyruvate and D-erythrose-4-phosphate, respectively. Together, these two pre-
cursors form shikimic acid. Shikimic acid is a central intermediate, serving as a branching 
point from which the phenolics compounds are obtained after several series of biosynthetic 
reactions (Dewick 2002; Lin et al. 2016). 
 
Flavonoids constitute a large division of plant phenolics. They are ubiquitously found in 
many plants including dietary foods like fruits and vegetables (Yao et al. 2004; Panche et al. 
2016). Being the most prevailing SMs present in almost all plants, flavonoids receive a great 

















Fig. 2. Representatives of phenolic SMs 
 
Their structures contain mainly two phenolic rings, A and B, linked via a heterocyclic pyran 
ring, C (Fig. 3) from which the major classes of flavonoids are derived as flavone, flavonone, 
flavonols, flavanonol, flavan-3-ols, and isoflavones (Kumar and Pandey 2013). They occur 
either as free aglycones or as glycoconjugates. Both structural forms are then nicely decorat-
ed through different degree of hydrogenation, hydroxylation and methoxylation giving rise to 







Fig. 3. Basic structure of flavonoids 
 
In addition to their essential roles in plant growth and defense responses, flavonoids also pos-
sess versatile health benefits (Xiao et al. 2011). Flavonoids are potent antioxidants and che-
lating agents (Pietta 2000); this property was claimed to be responsible for most of the bio-
logical activities exhibited by flavonoids (Heim et al. 2002), which is obviously illustrated 
Gallic acid             Cinnamic acid            Coumarin                         Podophyllotoxin 
              Curcumin                                     Luteolin                           Resveratrol 
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through their cardiovascular protective effects evoked by inhibition of LDL oxidation. They 
also showed antimicrobial (Cushnie and Lamb 2005; Jucá et al. 2018), anti-inflammatory 
(Rathee et al. 2009; Pan et al. 2010), and anticancer (Chahar et al. 2011; Batra and Sharma 
2013) potentials. Flavonoids are reported to modulate the cytochrome P450 enzyme system 
(Hodek et al. 2009). They have shown inhibitory activity against AChE (Roseiro et al. 2012; 
Xie et al. 2014; Khan et al. 2018), α-glucosidase (Proença et al. 2017), and xanthine oxidase 
(Pirouzpanah et al. 2009). Thus, attracting an increased curiosity to their therapeutic im-
portance in relevant diseases like AD, myasthenia gravis, glaucoma, diabetes, and gout. 
  
Terpenoids are regarded as the largest and oldest class of SMs occurring in plants (Caputi 
and Aprea 2011). The building block of terpenoids is the isoprene, which is a five-carbon 
unit. The biosynthesis of terpenoids is compartmentalized, i.e. in cytosol, the mevalonate 
pathway is the source of isoprene unit, leading to the formation of sesquiterpenes and triter-
penenes. While in plastids, the methyl-D-erythritol-4-phosphate pathway supplies the C5 
unit, from which the other terpenoids are usually derived, e.g. monoterpenes, diterpenes, and 
tetraterpenes. Terpenoids have broad applications in industry as flavors, fragrances, spices, 
and in perfumery and cosmetics (Caputi and Aprea 2011). In addition, terpenoids have been 
proven to display a potent anticancer activity (Patlolla and Rao 2012), a major example is 
paclitaxol (Slichenmyer and Von 1991) and anti-malarial, e.g. artemisinin (Fig. 4) (Krungkrai 
and Krungkrai 2016). 
 
Nitrogen-containing compounds, e.g. alkaloids. Alkaloids are low molecular weight 
compounds containing one or more nitrogen atoms in their structures, which impart the basic 
characters to these chemicals. They are usually subdivided according to the nitrogen-
containing structure (e.g. pyrrolidine, piperidine, quinoline, isoquinoline, indole) (Dewick 
2002). Alkaloids feature the SMs of many plant families like Apocynaceae, Asteraceae, Pa-
paveraceae, and Solanaceae. They have numerous bioactivities including, anticancer, e.g. 
vincristine (Fig. 4) & vinblastine, antimicrobial, antiparasitic, and estrogenic (Aniszewski 
2007). Despite their vast medicinal properties, alkaloids are also known to be highly poison-

















Fig. 4. Chemical structure of artemisinin and vincristine.   
 
1.4. Flora of Egypt as a source of medicinal plants 
 
Egypt is located in the northeastern corner of Africa, but also linked to Asia through Sinai 
Peninsula. Egypt's location is unique, as it represents the point of convergence for floristic 
features of four phytogeographical regions (EL Hadidi and Hosni 1996). Egypt has a sever 
arid climate with a mean temperature exceeding 30 ºC in summer and average annual rainfall 
of 100 mm and as little as 50 mm in the extreme deserts (Hegazy and Lovett-Doust 2016). 
Flora of Egypt comprises more than 2000 plant species hosting 48 endemic taxa belonging to 
18 families (Abdelaal et al. 2018). Sinai Peninsula with its distinct landform and geographical 
position holds the high number of endemism in Egypt (approximately 26 species); most of 
these endemic species are concentrated in St. Catherine region (Ayyad et al. 2000). The ele-
vated mountains impart a high floristic diversity to the area. However, stressing environmen-
tal impacts (e.g. climate change) and some human activities (e.g. urbanization and over graz-
ing) resulted in a growth disturbance to most of the area’s endemic species. Several species 
are currently classified by IUCN as being endangered, e.g. Anarrhinum pubescens or critical-
ly endangered species like Primula boveana.  
Historically, Egyptian plants have served as medicines since early times. Ancient Egyptians 
documented their medicinal recipes on the wall of temples and some have been recorded in 
Ebers Papyrus. Interestingly, many of these medicinally valued herbs are still in use till cur-
rent time (Saxena 2001).  
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Taking into account the historical standpoint of the medicinal plants of Egypt and the stress-
ing environmental/human influences, which suggested the induction of secondary metabolites 
to help plants to survive, the chemical and biological evaluation of the native Egyptian spe-
cies could reveal promising bioactive/lead metabolites. 
 

















Fig. 5. Photographs of wild P. boveana.  
 
1.4.1.1.  Taxonomic classification  
 







Kingdom        Plantae 
Subkingdom Tracheophyta 
Division         Magnoliophyta 
Class              Magnoliopsida 
Order             Primulales 
Family           Primulaceae 
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1.4.1.2. General morphological characters and geographical distribution  
 
Primula plants are perennial herbs, slightly to moderately succulent, bloom mostly in 
spring. Leaves are usually developed in single rosettes with omitted or obscured petiole. 
Leaves have different shapes: blade linear, broadly lanceolate, oblanceolate, oblong-obovate, 
rhombic, or elliptic to cuneate or spatulate. Flowers often heterostylous; sepals are 5, green, 
calyx broadly campanulate to cylindric or urceolate, and glabrous; petals are 5, lavender, ma-
genta, pink, rose, violet, white, or yellow (Richards 2003; Bawri et al. 2014). 
Primula is the largest genus in the family Primulaceae; it comprises more than 400 species. 
They inhabit mainly the temperate regions, so, widely distributed over Asia and Europe with 
a major occurrence in Himalayas and the European Alps (Richards 2003; Bawri et al. 2014). 
Primula boveana Decne. ex Duby (also known as Sinai primrose) is an endemic species 
to Mount St. Catherine in Sinai peninsula of Egypt. It grows wild in the high mountainous 
areas, particularly moist ground close to the wells	in	Gebel Musa, Gebel Safsaf, Gebel Serbal 
and Gebel Umm Shaumar. Currently, the total number of the plant's populations shows an 
increasing decline due to the harsh environmental such as the climate change as well as some 
human activities (Jimènez et al. 2014; Zaghloul et al. 2016), hence the species has been clas-
sified as a critically endangered plant (Mansour et al. 2013; IUCN 2014). Owing to the lim-
ited access to the plant, phytochemical and/or biological properties of the plant have not thor-
oughly studied yet. 
 
1.4.1.3. Biological activities of genus Primula 
 
Primula plants are recognized for their richness in several phyto-constituents belonging to 
different chemical classes, however, phenolic and saponin compounds were found as major 
secondary metabolites produced by these plants. These phytochemicals have imparted signif-
icant bioactivities to the plants of the genus. The most common medicinal use of the Primula 
is as antitussive. Herbal preparation from the underground organs (roots) and/or flowers of P. 
veris L. as well as P. elatior L. Hill are equally indicated for treatment of a range of respirato-
ry disorders such as productive cough, bronchitis, whooping cough, and asthma; this could be 
traced to the secretolytic potential of the triterpenoidal saponin constituents. These medicinal 
indications have been also described in the European pharmacopeia (EMA 2012). Alongside, 
many other bioactivities have been reported to these two species as well as to other species. 
Primula sp. have demonstrated remarkable antimicrobial activities. Najmus-Saqib et al. 
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(2009) verified the antifungal activity of P. macrophylla D. Don crude extract and its pre-
pared fractions. The methanolic extract of P. auriculata Lam. flowers showed antibacterial 
activity against nine Gram positive and Gram-negative bacterial strains (Jaberian et al. 2013). 
P. veris flower extract and P. vulgaris Huds. leaf extract showed significant antibacterial 
properties against a number of Gram-positive and Gram-negative bacteria (Başbülbül et al. 
2008; Majid et al. 2014). Also, the antioxidant activity was amongst the recorded biological 
characteristics of the genus Primula, which could be due to their high contents of the phenol-
ic compounds. Many Primula species demonstrated antioxidant activities (Jaberian et al. 
2013; Mostafa et al. 2014). Some other bioactivities displayed by Primula plants include: cy-
totoxic, antidiabetic, and anti-inflammatory actions (Tokalov et al. 2004; Najmus-Saqib et al. 
2009; Singh et al. 2014).  
 
1.4.1.4. Chemical constituents of genus Primula 
 
Plants belonging to genus Primula accumulate excellent amount of plant phenolics and 
triterpenoidal saponins as their main phyto-constituents. Flavonoids are the predominant phe-
nolic present in Primula; however, other phenolic classes are reported but less frequently. 
Studies on the phenolic contents of Primula dates back to the beginning of twentieth century 
(Colombo et al. 2017). Primula plants are well-known for their epicuticular flavonoids which 
primarily composed of flavonoids aglycones being hydroxylated and/or methoxylated at dif-
ferent degrees. The function of these surface-secreted metabolites is still unclear. Neverthe-
less, these lipophilic exudates were claimed to play crucial protection roles in plants. They 
protect against UV-radiation acting as natural screens, pathogens, and herbivorous attack 
(Cuadra and Harborne 1996). Exudate flavonoids have been also proven to possess relevant 
adaptation functions in freezing temperature, assisting the plant to tolerate the extremely low 
temperature (Isshiki et al. 2014). The chemical structures and occurrence of the major exu-



















Species  R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 
H H H H H H H H H H 1-3, 6-10, 13-16, 18-20, 22 
OH H H H H H H H H H 1,2, 7, 9, 13-16, 18, 20 
OMe H H H H H H H H H 6, 9, 10, 15, 17-19 
OH H H OH H H H H H H 9, 15, 16 
OMe H H OMe H H H H H H 17, 18 
OH H H OAc H H H H H H 3, 6, 8-10, 19, 22 
H OMe H H H H H H H H 1, 10, 17-19 
H OH OH H H H H H H H 2, 13, 16 
H OMe OMe H H H H H H H 1,2, 17-19 
H OH OMe OMe H H H H H H 17-19 
H OMe OMe OMe H H H H H H 17-19 
H OH H OH H H H H H H 13 
H OH OMe OH H H H H H H 17 
H H OH H H H H H H H 1,2, 13, 15 
H H H H H H OH H H H 2-4, 7-9, 13-16, 19, 20, 22 
OH H H H H H OH H H H 2, 9, 13-15, 20, 22 
OMe H H H H H OH H H H 15 
OMe H H H OMe H OMe OMe H H 18 
OMe OMe H H OMe H OMe OMe H H 17 
H H H H H H OH H OH H 15 
H H H H H H OH H H OH 2, 3, 6-8, 10, 13, 15, 20 
OH H H H H H OH H H OH 9, 22 
H H H H H H H H OH OH 15 
OH H H H H H H H H OH 9, 5 
OH H H Benzoate H H H H H OH 9 
 
*Species names: (1: P. albenensis, 2: P. auricula: 3: P. glaucescens, 4: P. glutinosa, 5: P. pulverulen-
ta, 6: P. hirsuta, 7: P. marginata, 8: P. minima, 9: P. palinuri, 10: P. latifolia, 11: P. spectabilis, 12: 
P. villosa, 13: P. farinosa, 14: P. frondosa, 15: P. halleri, 16: P. nutans, 17: P. elatior, 18: P. veris, 
19: P. vulgaris, 20: P. denticulata, 21: P. officinalis, 22: P. macrophylla). References: (Wollenweber 
et al. 1988; Huck et al. 1999, 2000; Budzianowski et al. 2005; Bhutia and Valant-Vetschera 2012; 
Colombo et al. 2017).  
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In addition to epicuticular flavonoids, Primulas are also capable of producing many tissue-
type flavonoids. These are mainly polar flavonoids derived from flavone or flavonol subunits 
that are mostly O-glycosylated with one or more sugar at varying positions through the mole-
cule.  
Apart from phenolic constituents, triterpenoidal saponins form another major group of 
metabolites that largely distribute in the roots of Primula plants. Generally, the identified 
saponins contained the triterpene aglycone, protoprimulagenin A, which gave rise to different 
saponins known from the genus after O-glycosylation with several sugars at the position C-3. 
Paola et al. has reviewed the saponins occurred in European Primula and concluded them as: 
primulasaponin I, primulasaponin II, priverosaponin B 22-acetate, and priverosaponin B 22-
acetate (Colombo et al. 2017). 
 
























1.4.2.1. Taxonomic classification  









1.4.2.2. General morphological characters and geographical distribution 
 
A. pubescens Fresen. is a glandular-hairy perennial shrub, usually 30-60 cm length. Stems 
are erect and branched from the base. Basal leaves oblanceolate, coarsely dentate in the upper 
part, acute, the base attenuate into a petiole 3-8 mm. Inflorescence is raceme, corolla is white 
in color (Bolus 2000). Genus Anarrhinum is generally distributed over the Mediterranean re-
gion; represented in Egypt by A. pubescens, which grows on the high altitude rocky moun-
tains of Sinai Peninsula.  
 
1.4.2.3.  Biological activities of genus Anarrhinum 
 
Iridoids are abundant metabolites in the genus Anarrhinum and the reported biological ac-
tivities of the plants from the genus have been mostly done on the isolated iridoids. However, 
a full biological investigation of the genus is not thoroughly studied yet. So far, only two bio-
activities assessed on the Anarrhinum plants. One was concerned with the cytotoxic activity 
of some iridoids isolated from A. pubescens against the human lung carcinoma cell line (A-
549); the dimer iridoid, pubescensoside, showed a better activity compared to other iridoids 
reported in the study (Mahran et al. 2018). In addition, Salah El Dine et al. (2011) evaluated 
the hepatitis C virus protease inhibitory activity of some iridoids isolated for A. orientale 
Benth.; two of these iridoid metabolites showed a moderate inhibitory activity against the en-
zyme. Many studies have reported the bioactivities of iridoids as a potent biologically active 
class of natural compounds. Numerous pharmacological activities like antimicrobial, antidia-
betic, anti-hyperlipidemic, antioxidant, hepatoprotective, and immunomodulatory activity 
were described for iridoid compounds obtained from plants (Tundis et al. 2008; Dinda et al. 
Kingdom        Plantae 
Subkingdom Tracheophyta 
Division         Magnoliophyta 
Class              Magnoliopsida 
Order             Lamiales 
Family           Plantaginaceae 
Genus            Anarrhinum 
species       pubescens Fresen. 
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2011). Iridoids showed also anti-inflammatory (Park et al. 2010) and anticancer potential 
(Dinda et al. 2011). Iridoids exhibited lipoxygenase inhibitory activity (Gousiadou et al. 
2013). 
 
1.4.2.4. Chemical constituents of genus Anarrhinum 
 
Iridoids were identified as the main phytochemicals occurring in plants of genus Anarrh-
inum. They are bicyclic monoterpene metabolites; mostly present as glycosides. Structurally, 
iridoids are considered as cyclopentane-(c)-pyran-derived compounds. Iridoid compounds 
originate from geraniol by a type of folding that looks different from monoterpenoids 
(Dewick 2002). Methylerythritol phosphate (MEP) pathway is the main biosynthetic pathway 
of monoterpenes and assumed to be a site-specific, i.e. biosynthesis of monoterpene takes 
place in plastids where MEP pathway is the main supplier of the isoprene units. Iridoids as a 
characteristic group of natural products have a significant role in chemotaxonomy of some 
plant families where they marked the phyto-constituents of these families (Jensen et al. 2002; 
Taskova et al. 2002). 
Plantaginaceae family is an important source of iridoids (Fuchs and Bowers 2004; Taskova et 
al. 2010; Kroll-Møller et al. 2017). Aucubin, catalpol and their derivatives are the most 
known iridoids present in Plantago sp. (Taskova et al. 2002; Fuchs and Bowers 2004). Iri-
doids characterized in Anarrhinum plants were determined as derivatives of either antirrhino-
side or mussaenosidic acid. They were mainly esterified with foliamenthoic acid and/or cin-
namic acid. These characteristic structural features could be a useful chemotaxonomic marker 
for the genus. The structures of the iridoids isolated from A. orientale and A. pubescens are 

















































1.5. Phytochemical and biological analysis of plants 
 
Plants contain a huge number of metabolites distributed all over its parts. Knowledge of 
the plant metabolites would be of worth applications in many scientific disciplines such as 
phytochemistry, phytomedicine, plant physiology, taxonomy, and ecology. Nonetheless, the-
se metabolites are belonging to broad chemical classes with different physicochemical prop-
erties. Meaning, the comprehensive chemical and/or biological investigation of these metabo-
lites would be a challenging research. The availability of the plant material is also a crucial 
aspect, as analysis could be significantly hampered if the plant material is very rare or has a 
restricted access. Accordingly, the analytical methods intended for metabolites analysis 
should be thoroughly considered in terms of their separation and detection efficiency as well 
as the amount of sample consumption. As species selected in this study are regarded as a rare 
material; the access to a large amount is considerably restricted, the amount of sample con-
sumption for analysis should be considered. 
Currently, hyphenated techniques have been widely developed and multiple analytical in-
struments can be linked together in order to overcome the aforementioned challenging as-
pects. So, these hyphenated systems have a special importance in the field of discovery of 
lead therapeutic agents from plants (Wolfender et al. 2006; Patel et al. 2010). The most 
commonly used online hyphenated instruments are TLC-UV/Vis/FLD, HPLC-MS, and GC-
MS. Furthermore, extension of the hyphenation to involve a streamlined biological evaluation 
of the studied samples has been made available and witnessing many interesting innovations, 
e.g. HPTLC-EDA. Hyphenations is beneficial in chemical and biological analysis, it gener-
ates massive information like chromatographic, spectral, and structural properties, leading to 




Thin layer chromatography and its optimized form, HPTLC, are the most popular catego-
ries of planar chromatography. Stationary phase of TLC has been supremely optimized in 
order to suit the high performance separation and that give rise to the development of 
HPTLC. The main characteristic feature of HPTLC is that the stationary phase is composed 
of small-sized silica particles, allowing higher packing density and smother surface resulting 
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in better compound resolution, improved detection, and faster analysis time than the classical 
TLC (Spangenberg et al. 2011). 
HPTLC complements HPLC and despite the separation superiority of HPLC, HPTLC still 
offers several other crucial compensatory options making it more preferable in many cases 
(Morlock and Schwack 2010). HPTLC permits parallel separation of compounds mixture in 
one run, resulting in a high sample throughput and analysis of multiple samples under identi-
cal conditions. Also, HPTLC allows flexible use of different stationary phases where a new 
stationary phase should be used for each analysis, thus, avoiding cross sample contamination 
and the sample cleaning is not necessary prerequisite for analysis. 
Another major difference lies in the detection of the separable components. In HPLC, sample 
detection is achieved while they are in the mobile phase leading to many unavoidable re-
strictions in the mobile phase composition. In contrast, (HP)TLC permits detection after 
complete removal of the residual mobile phase, hence, excluding any interference to the 
measurements (Morlock and Schwack 2010; Spangenberg et al. 2011). 
 
1.5.1.1. (HP)TLC-based hyphenated techniques 
 
Considering the distinguished features of (HP)TLC, hyphenation become an increasingly 
adopted approach in planar chromatography. The reason is that the analytical task could be 
achieved for every individual component without worry of any possible mobile phase inter-
ference. Notably, automated instrumentation of (HP)TLC to involve almost all chromato-
graphic steps has forcibly derived the hyphenation to more promising applications. The hy-
phenation of (HP)TLC involves coupling of the chromatograms to different spectroscopic 
instruments and/or bioactivity assays, giving rise to broader applications of (HP)TLC. 
The spectroscopic means facilitate the structural identification of the separated substances 
while still residing on the plate; this considerably eliminated the need to preparative isolation 
of these metabolites which seems laborious, tedious and time consuming procedures. The 
UV, Vis, FLD, Fourier-transform infrared, MS, and HRMS are different structure elucidating 
means that have been successfully linked to (HP)TLC (Morlock and Schwack 2010). 
Moreover, the hyphenation has been extended to include the bioactivity assays. Through this 
combination, the bioactivity of individual components contained in a single or multiple sam-
ple(s) could be directly evaluated on the developed plates, so-called "Effect directed analy-
sis". A wide range of bioactivities is currently performed using this strategy, e.g. antioxidant 
 
	 20	
activity or testing the inhibitory potential against either biological enzymes or biosystems, 






















Fig. 8. Schematic representation of (HP)TLC-based (bio)analytical hyphenations (Morlock and 
Schwack 2010, Dewanjee et al. 2015). 
 
Biodensitometric measurement after application of the (bio)assays can also be performed 
using the TLC scanner. It mainly gives an indication regarding the potentiality of studied in-
hibitors through measuring the peak area of the inhibition zones, which in most of the cases 
appear as white spots vs. the colored background. Noteworthy, the inhibitory impact generat-
ed by the compounds can be biologically referred to that of a known standard inhibitor. Thus, 
providing comprehensive biocomparison information. 
In summary, linking HPTLC to the (bio)analytical methods places this technique steps a 
head from many other conventional methods. It leads to high-throughput detection of poten-
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tial drugs, remarkably from natural sources, like antimicrobials, antioxidants, and enzymes 





HPLC-MS is another common hyphenated system. It interfaces the chromatographic 
technique to various detection methods like UV and mass spectrometer, thus, allowing on-
line separation and identification of compounds in a complex mixture.  
Due to the diverse nature of plant metabolites, a universal method for separation, detection, 
and identification is practically not possible. Hence, HPLC-based hyphenation has been 
greatly advanced in order to suit these a broad needs. The chromatography part (HPLC) con-
sists of five main components: solvent reservoir, pumps, sample inlet, column compartment, 
and detector. Based on the column dimension and working flow rate, the HPLC instruments 
are usually classified as preparative, analytical, micro, nano, and chip HPLC (Waksmundzka-
Hajnos and Sherma 2010). The most widely used packing material for HPLC columns is sili-
ca which could be modified to work under different separation modes such as normal phase 
or reversed phase. 
With regard to the detection methods, a purpose-based classification is reported. So, for just 
recording the chromatographic traces, UV, evaporative light scattering detectors or electro-
chemical detectors would be suitable. While, the UV-DAD (photodiode array detection) and 
MS detectors are considered appropriate for compounds identification objectives (Larson et 
al. 2000). Although considered as a relatively expensive when compared to other detectors, 
MS still one of the most selective and sensitive detector for analysis of natural products. The 
principle task of mass spectrometers is to aid in the structure elucidation of compounds from 
the conveyed molecular mass information. When coupled to HPLC, MS could be satisfactory 
for identification of the individually resolved compounds from complex matrices. Typically, 
all mass spectrometers constructed of three main parts ion source, mass analyzer, and detec-
tor. 
Mass analysis starts with the most crucial step, which is the conversion of the introduced neu-
tral molecules into a gas phase while ionizing them. Several ion sources are available differ-
ing principally in the way they transfer the molecular species into gas phase and affecting 
ionization. Ion sources could be either hard techniques like electron ionization or soft tech-
niques as in case of chemical ionization, electrospray ionization, and matrix-assisted laser 
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desorption ionization (Bhardwaj and Hanley 2014). Electrospray ionizers are the most widely 
used ionization sources, even though, it poorly ionize the nonpolar compounds. The ioniza-
tion occurs under the atmospheric pressure leading eventually to isolated gas-phase ions. The 
mechanism involves passing the liquid analyte through a capillary maintained at a high elec-
trostatic voltage (3-5 kV). This generates a mist of micrometer-sized electrically charged 
droplets, which upon evaporation of the solvents would shrink and disintegrate into fine par-
ticles leading to formation of the isolated gas-phase ions (Fenn et al. 1990; Wilm 2011; 
Medhe 2018). The ion beam is now directed towards the mass analyzers working under high 
vacuum conditions. Various types of mass analyzers have been developed utilizing different 
modes of ion separation. Common mass analyzer devices include: Time-of-flight, Magnetic 
sector, Linear quadrupole, Linear quadrupole ion trap, Quadrupole ion trap, Fourier trans-
form-ion cyclotron resonance, and the most recent Orbitrap analyzers (Pitt 2009). Till now 
the first two steps of mass measurement have been accomplished, i.e. ion generation and sep-
aration, but still the visual translation into an informative data remains as an exclusive func-
tion to the detectors. In general, ion detectors receive a lesser attention in mass reviews than 
ion sources and mass analyzers, although it represents an integral role in analysis output. Two 
common ion detectors have been discussed mostly in many reports, Faraday and electron 
multiplier detectors (Koppenaal et al. 2005). 
The development of tandem mass analysis (MS/MS or MSn) has a spectacular impact on 
structural characterization of components of a complex mixture, in particular, when it is cou-
pled to HPLC. The idea that features the MS/MS process is that two mass analyzers are con-
nected in series (either in space or time) with a collision compartment in between (Snyder et 
al. 2018). Tandem mass analysis could be performed in different modes depending on the 
mass information needed, however, all modes could be integrated together to permit structur-
al determination of the measured analyte. Four scan modes are widely used so far in tandem 
mass experiments: product ion, precursor ion, neutral loss, and single reaction monitoring 
(Fig. 9). In product ion scanning, which is frequently used, the first mass analyzer (MS1) is 
selected while the third mass analyzer (MS3) is scanned over a mass range and in between is 


























Fig. 9.  Possible scan modes of tandem mass analysis (shapes represent different ion species). 
 
With high selectivity and sensitivity of the different scan modes of MS/MS, a high 
throughput phytochemical screening of botanical extracts has been achieved (Yang et al. 
2009; Stylos et al. 2017). Phenolics, with its major subdivision, flavonoids, have been exten-
sively studied by HPLC-MS/MS means (March and Brodbelt 2008; Kachlicki et al. 2016), 
the reason could be their ubiquitous abundance, physiological roles in plants, and broad 
health benefits. Sequential mass information obtained through precursor ion fragmentation 
allowed complete analysis of phenolics exist in conjugated forms (Stobiecki et al. 2010; 
Orčić et al. 2014). Characteristic loss or cleavage of the molecule composional unites could 
be easily determined from the difference between the m/z of the parent and daughter (frag-
ment) ions. Flavonoids are mostly occur as glycoconjugates with aglycone part is being at-
tached to sugar (mono-, di-, tri-, and tetra-) and in many cases one or more of the aglycone or 
sugar OHs is acylated with different aliphatic (acetyl and malonyl) or aromatic (benzyl, cin-
namoyl, coumaroyl, galloyl, feruloyl, and sinapoyl) acyl groups. So, assignment of the con-
jugated moiety can be known from the mass of the diagnostic fragment. For examples, loss of 
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mass units equal to 162 indicates (hexose unit), and 146 (deoxy sugar), 152 (pentose), 86 
(malonyl), 146 (coumaroyl) (Cuyckens and Claeys 2004).  
 
1.6. HPTLC-GUS  
 
1.6.1. Glucuronidation and deglucuronidation  
 
In general, the process of xenobiotics detoxification involves two metabolic phases name-
ly, phase I and phase II. phase I is mostly considered as a preparatory process. The reactions 
executed in phase I involve oxidation, epoxidation, hydroxylation, dealkylation, hydrolysis, 
or similar modifications that result in formation of a slight enhancement in the polarity of the 
metabolites. In phase II, the products of phase I and the xenobiotics themselves, if having the 
proper functional groups, is conjugated with an endogenous polar moiety, giving rise to high-
ly polar metabolites that are readily excreted from the body through the bile (Hodgson 2010).  
Examples of the endogenous conjugating moieties are sugars, amino acids, sulfate, and ace-
tate. Therefore, the phase II metabolism is considered as a detoxification process, such that 
helps the body to eliminate the administered xenobiotics like pesticides, food-borne carcino-
gens, and drugs.  
 
Glucuronidation is a common phase II detoxification reaction. It is the major pathway for 
elimination of many xenobiotics. Compounds with functional groups like -OH, -COOH, and -
NH2 are possibly conjugate with the glucuronide source, uridine-5′-diphosphoglucuronic ac-
id, employing uridine diphosphate glucuronosyl transferase as a catalytic enzyme (Baynes 
and Hodgson 2010). Although, glucuronidation plays an essential role in elimination of xe-
nobiotics, the rate is suggested to be limited by the deglucuronidation process mediated by 
GUS. The enzyme leads to release of the glucuronide moiety through hydrolysis mechanism, 
yielding the original unconjugated form of the parent compounds. Therefore, increasing the 
possibility of their re-absorption into the circulation system and subject the body to prolonged 







1.6.2. GUS inhibition  
 
Potential health consequences of such hydrolytic reactivation of glucuconjugated xenobi-
otics or drug metabolites by GUS have been widely reported. Some examples of xenobiotics 
that typically eliminated by the glucuronidation route but retrieve their activity after being 
deglucuronidated by GUS are here given: 
• 4-(methylnitrosamino)-1-(3-pyridy)-1-butanone and 1,2-dimethylhydrazine are pro-
ducers of reactive oxygen species that lead to DNA damage, mutagenesis, and carcin-
ogenesis and reactivation of their glucuconjugated metabolites leads to intestinal inju-
ry and colon cancer (Cheng et al. 2015). 
• Irinotecan (CPT-11), a potent anticancer drug and reactivation of the glucuconjugated 
metabolite results in a serious chemotherapy-induced diarrhea (Roberts et al. 2013). 
• Nonsteroidal anti-inflammatory drug, reactivation of the glucuconjugated metabolite 
leads also to intestinal injury (Roberts et al. 2013).   
Thus, it becomes obviously evidenced that inhibition of GUS would be of pivotal health ben-
efits.  Intriguingly, reactivation of the readily glucuconjugated metabolites is highly specific, 
in such a way that it takes place only by GUS of the gut bacteria, e.g. E. coli, rather than the 
human orthologs (Cheng et al. 2015). Accordingly, several lead drugs have been emerged as 
selective inhibitors that solely inhibit the bacterial GUS; the introduced inhibitors didn't alter 
the activity of the parent drug or even harm the bacteria or human cells (Wallace et al. 2010; 
Pellock et al. 2018).   
 
1.6.3. GUS inhibition assay 
 
As a selective marker for detection of the enteric bacteria, e.g. E. coli in food, water, and 
environmental samples, GUS assays have been adequately proposed. With growing interest 
in finding an appropriate substrate for the histochemical demonstration of GUS, detection 
assays of the enzyme have been well advanced. Two methods of detection, fluorometric and 
colorimetric, have been reported frequently in literature.  
Fluorometric assay uses 4-methylumbelliferyl-β-D-glucuronide as a substrate, which upon 
hydrolyses with GUS, releases the fluorogenic 4-methylumbellifon as an end product that 
could be observed at a longer UV light (366 nm) (Moberg 1985). Colorimetric assay, as re-
ferred from the name, results in a colored product typically after hydrolysis of the substrate 
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by GUS. A variety of chromogenic substrates have been evolved for this purposes, e.g. p-
nitrophenyl-β-D-glucuronide (Kim et al. 1999), phenolphthalein-β-D-glucuronide (Lampe et 
al. 2002), naphthol derivatives (Jeffree 1969), and indoxyl-β-D-glucuronide (Haines et al. 
1993).  
 
One other sensitive GUS substrate is X-Gluc (Frampton et al. 1988). The substrate works ef-
ficiently for histochemical localization of GUS in plants giving a blue-colored precipitate at 
the presumptive sites of the enzyme activity (Jefferson 1987). It also showed a profound ca-
pacity to detect E. coli bacteria in clinical samples (Wu et al. 2018). The reaction mechanism 
of such substrate involves at first hydrolytic cleavage affording the colorless indoxyl inter-
mediate, which undergoes further oxidation by the atmospheric oxygen and ultimately dimer-
ization takes place to yield the end product as a blue-colored precipitate, dichlorodibromoin-


















The occurrence of SMs in plants is highly influenced by several exogenous factors, among 
which the environmental ones are regarded as key contributors. Plants accumulate such me-
tabolites as a part of their defense mechanisms in an effort to survive. In addition to their 
beneficial roles in plants, SMs display wide scope of important pharmacological activities, 
favoring their use as medicines in several diseases. Plants growing endemically in St. Cathe-
rine region in Egypt are exposed to many stressing impacts, which might induce some inter-
esting chemical and/or biological properties.  
To prove the relevant bioactivity of SMs present in any studied material, standardized 
(bio)assays are necessarily followed. The emergence of several streamlined hyphenation 
techniques that couple the chromatographic separation to the bioactivity testing have consid-
erably reduced the experiment time as well as the sample consumed; made it possible to di-
rectly track the bioactive metabolites in the botanical material. With the formentioned motifs 
in mind, the current study was designed with the following aims. 
                                                              2. Aims and objectives 
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1. Biologically guided isolation of the bioactive metabolites from two plant species growing 
natively in St. Catherine region in Egypt, namely P. boveana (Primulaceae) and A. pu-
bescens (Plantaginaceae), along with one medicinally important plant, P. veris (Primula-
ceae). 
2. Development of a new HPTLC-EDA hyphenation for the simultaneous detection of GUS 
inhibitors present in complex matrices with a particular focus on verification to botanical 
material.  




1. Implementation of the HPTLC-EDA technique as a straightforward, material saving 
methodology for biological screening of the studied plant species. With this objective, the 
cutting-edge technologies in chromatography and (bio)assay application on HPTLC are 
intended for use. 
2. The bacterial and AChE/BChE inhibitory activities were considered for biological screen-
ing of P. boveana and P. veris. 
3. Investigate the A. pubescens extract for the presence of active AChE inhibitors. With this 
objective, we planned to provide wider insights with regard to the ChE inhibitory activity 
of iridoids occurring in the plant. The outcomes would advance and support the applica-
tion of iridoids in neurodegenerative diseases like AD. 
4. Structure elucidation of the bioactive metabolites detected in the studied plant extracts 
and, when necessary, compounds separation should be also carried out. 
5. Establishment of HPTLC-GUS inhibition assay hyphenation. The developed protocol 
would be optimized, validated, and verified. 
6. HPLC-HRMS and tandem mass analysis of P. boveana. Considering its critically endan-
gered status and the lack of information regarding its chemical constituents, P. boveana is 

















Primula veris L.: dried flowers were purchased from Caesar & Loretz GmbH (Hilden, Ger-
many). 
Primula boveana Decne. ex Duby: leaves were collected (June, 2017) from Shag Mousa area 
                            in St. Catherine, Egypt; authenticated by Prof. Hasnaa Hosni, Professor of 
Flora and plant taxonomy, Cairo University Herbarium. 
A. pubescens Fresen.: Arial parts were collected (April, 2015) from Wadi El-Arbeen in St. 
Catherine, Egypt; authenticated by the taxonomy staff members of St. 
Catherine protectorate. 
 
                                                          3. Material and Methods 
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Solvents and reagents 
All solvents used for extraction and chromatographic separations in this study were high puri-
ty grade solvents and obtained from Fischer Scientific, Acros Organics, and VWR (Germa-








AChE, BChE, GUS were purchased from Sigma-Aldrich (Steinheim, Germany). 
 
Microorganisms 
B. subtilis spore suspension (2.0 ml ampoules) from Merck, product No. 110649 (Darmstadt, 
Germany), Luminescent A. fischeri strain (Leibniz Institute DSMZ-German Collection of 
Microorganisms and Cell Cultures, Berlin, Germany). 
 
Growth media 
B. subtilis was cultured on Mueller-Hinton growth medium, product No. 70192 (Sigma Al-
drich, Germany), optical density of the bacterial suspension was monitored using spectropho-
tometer (M501, SpectronicCamspec, Leeds, UK). A. fischeri growth medium was prepared 
according to DIN ENISO, Section 5 (DIN 2009) and contained in 1 L of H2O, NaCl (30 g), 
NaH2PO4.H2O (6.1 g), K2HPO4 (2.75 g), MgSO4.7H2O (0.204 g), (NH4)2HPO4 (0.5 g), glyc-
erin (3.0 mL), peptone from casein (5 g), and yeast extract (0.5), pH adjusted to 7.0 with 20% 
NaOH solution or 1M HCL. 
 
Substrates and reagents  
α-Naphthyl acetate was from BioChemica (Germany), X-Gluc (Carbosynth, Berkshire, UK), 
SFLG, Fast Blue B salt and Riv were from Sigma-Aldrich (Steinheim, Germany), MTT, p-
anisaldehyde, natural product reagent, and polyethylene glycol 400 were purchased from Carl 






Instruments for HPTLC application, development and documentation 
All HPTLC instrumental platform was from CAMAG (Muttenz, Switzerland) and included: 
Automatic Thin Layer Chromatography (ATS-4), Automatic Developing Chamber (ADC2), 
TLC visualizer, TLC scanner 4, TLC derivatizer, BioLuminizer, TLC plate heater 3, Chroma-
togram immersion device III, smartCUT TLC Plate Cutter. 
 
Preparative HPLC and NMR 
Preparative HPLC isolation was carried out on DeltaPrep chromatography system, Waters 
(Milford, MA, USA) controlled by MassLynx V4.1 software. The instrument is equipped 
with preparative LC controller, fluid handling unit, dual λ absorbance detector 2487, and 
pumps (All Waters®, USA) and solvents were degassed with Helium gas. Column was RP-
column (vp 250/10/5 µm, Nucleodur C18, Macherey-Nagel, Düren, Germany). NMR: ECX-
400 (400 MHz), JEOL (Freising, Germany). 
 
HPLC-EPIMS, HPLC-HRMS, and HPTLC-MS 
HPLC-HRMS: HPLC system was Agilent 1100 series equipped with degasser (G1322A), 
Bin pump, auto-sampler, column compartment and DAD detector (Agilent 
Technologies Deutschland GmbH). Column was EC 250/4/5 (Nucleodur 
C18, Macherey-Nagel, Düren, Germany). The HPLC system was coupled 
with the hybrid LTQ-FT Ultra mass spectrometer (Thermo Fischer Scientific, 
Germany) hybrid mass spectrometer having a linear ion trap and Fourier 
transform ion cyclotron resonance as an analyzer. The ion source was ESI. 
EPIMS: EPIMS analysis was achieved on hybrid Q-Trap mass spectrometer (Applied Biosys-
tems SCIEX 2000, Darmstadt, Germany). The instrument is equipped with 
ESI source. Source temperature was 200 ºC and nitrogen was the nebulizer 
gas. Data were collected and processed using Analyst 1.1.4 software. Extract 
was introduced via the integrated syringe pump at a flow rate 10 µL/min. 
HPTLC-MS: mass analysis of eluted bands directly on chromatograms was achieved using 
HPTLC-MS interface (Plate Express, Advion, NY, USA) for online zone 
transfer       
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to the QExactiveTM PlusHybrid Quadrupole-Orbitrap mass spectrometer 
(Thermo Fisher Scientific, Germany). 
 
3.3. Biological evaluation and active metabolites identification in P. bo-
veana & P. veris 
 
3.3.1. HPTLC development 
 
The workflow of HPTLC procedures followed in this research is illustrated in Fig. 10. 
 
Sample preparation: 
Air-dried P. boveana leaves and P. veris flowers were finely pulverized using lab mixer. One 
gram of each plant powder was extracted with 10 mL mixture of toluene and EtOAc (1:1, 
V/V) for 24 h under continuous stirring. Each extract was filtered through 0.45 µm membrane 
filters (Chromafil®, Germany) and kept at  –20 ºC till analysis. 
 
Application, development and documentation:  
Applied volumes were optimized depending on the resulting separation pattern of samples as 
well as the appearance of the inhibition zones, so that to avoid any overlapping of eluted 
bands. Bands of 8 mm wide were applied using ATS-4. Chromatogram developed with mo-
bile phase composed of hexane : EtOAc (7:3, V/V) in Twin Trough Chamber (presaturated 
with the mobile phase for 3 min) up to 80 mm migration distance. Plates documented by the 
TLC Visualizer at UV 254 nm, 366 nm, and white light illumination (reflectance, transpar-
ence, and both modes together).  
 
Derivatization  
p-Anisaldehyde/sulfuric acid reagent was prepared by adding 5.0 mL conc. sulfuric acid to a 
mixture of 85 mL methanol and 10 mL acetic acid. Then, 0.5 mL of p-anisaldehyde was add-
ed. Developed HPTLC plates were sprayed with 3.0 mL of the reagent solution followed by 
heating at 105 ºC on the TLC plate heater for ca. 4 min. The chromatograms were document-
























Fig. 10. Experimental workflow of HPTLC-EDA pursued in the study 
 
3.3.2. HPTLC-antibacterial bioassay 
 
A. fischeri bioassay 
The bacterial suspension was prepared in the growth medium mentioned in section (3.2.1). 
The developed plates were immersed in the bacterial suspension (time 1 s, immersion speed 3 
cm/s). The inhibitory activity displayed by the active metabolites on A. fischeri was docu-
mented using the BioLuminizer set to capture an image every 2 min for a total of 10 images. 
Bioactive zones appeared as dark zones against a bright background. 
 
B. subtilis bioassay  
The bacterial suspension was initiated in a 250 mL Erlenmeyer flask contained 50 mL of 
Mueller-Hinton growth medium and inoculated with 2.0 mL bacterial spore suspension. The 
inoculated broth was incubated at 37 ºC under orbital shaking. Growth kinetics were moni-
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tored by measuring the OD600. Incubation continued until 9.0 ≤ OD600 ≤ 1.0 was obtained. 
Developed plates were dipped in the bacterial suspension for 3 s with an immersion speed of 
3 cm/s. Plates were incubated in a moistened, well-closed plastic box at 37 ºC for 2 h, then 
dipped into 0.2% Phosphate-buffered saline-buffered MTT solution (time 1 s, immersion 
speed 3 cm/s). After incubation for an additional 0.5 h at 37 ºC, inhibition zones appeared 
white against a purple background. The bioautograms were documented under white light 
illumination in the reflectance mode. 
 
3.3.3. HPTLC-AChE/BChE inhibition assay 
 
Solutions of both enzymes as well as the relevant substrates were piezoelectrically 
sprayed over the chromatograms using the TLC Derivatizer. Enzyme solutions were prepared 
as reported by Hage and Morlock (2017), and contained 666 units AChE or 334 units BChE 
in 100 mL 0.05 M TRIS buffer, pH 7.8 (0.1% BSA). Pre-wetting of the plates with 1.0 mL 
Tris buffer was done, followed by piezoelectric spraying of 3.0 mL of the enzyme solution. 
Excess liquid film allowed to be completely adsorbed by the plates before being incubated at 
37 ºC in moistened plastic containers for 30 min. After incubation, the plates were sprayed 
with 0.5 - 0.75 mL of the substrate mixture composed of α-naphthyl acetate solution (3 
mg/mL in methanol) and Fast Blue salt B dye (3 mg/mL in water). Active bands appeared as 
white zones against a purple background and results were documented with the TLC Visual-
izer at white light illumination. 
 
3.3.4. Active metabolites Identification  
 
Metabolites that showed inhibitory activities on either enzymes or microbes, as recog-
nized from their inhibition zones, were identified by to UV, HRMS, and NMR spectroscopic 
methods. UV spectra of compounds were recorded on the TLC scanner set to absorbance 
measurement and wavelength range (190 - 700 nm). For HPTLC-HRMS analysis, active 
bands were marked and eluted through the elution head-based interface using methanol as an 
eluent at a flow rate 0.1 mL/min (Fig. 11). Full scan mode was selected and covered a mass 
range 100-1000. Analysis performed on -ve polarity for P. veris and +ve polarity mode for P. 
boveana. ESI voltage was 3.5 kV (‒ 3.0 kV), nebulizer gas was nitrogen, and source tempera-
ture was set at 250 ºC. Data acquisition and processing controlled by Xcalibur 3.0.63 soft-




Bioactive compounds in P. boveana were further isolated using preparative HPLC. Sepa-
ration was achieved using an isocratic elution with 60% methanol in water. Injection volume 
was 100 µL per run and flow rate set to 3.0 mL/min. The detector was set at UV254nm and col-
lected fractions were evaporated under reduced pressure to obtain the active metabolites (Pb1 














Fig. 11. HPTLC-MS interface (elution head-based) with representative diagram showing the mecha-
nism by which compounds are eluted from the plate for MS analysis 
 
3.3.5. AChE inhibition equivalency calculation of Pb1 
 
The AChE inhibition equivalency study was performed in order to evaluate the AChE in-
hibitory activity exerted by the most active metabolite (Pb1) as equivalent to the well-know 
enzyme inhibitor, Riv. So, P. boveana extract was applied in triplicate using two different 
application volumes (0.5 and 0.1 µL) and bands were separated as described using the same 
mobile phase. Based on the area of the inhibition zones, the lower volume (0.1 µL) was used 
for accomplishing the equivalency calculation. Riv was applied on an edge of the chromato-
gram using the free mode option of the ATS-4. Five different amounts (1 - 10 µg/band) were 
applied as 8 mm-band track patterns. The HPTLC-AChE inhibition assay was performed. 
The standard calibration curve of the Riv was constructed and the regression equation was 
generated using Microsoft excel. Using this equation, direct substitution with the obtained 
area of inhibition of Pb1 was done and results expressed as Riv equivalent values. 
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3.4. Biological evaluation and active metabolites identification in A. pu-
bescens 
 
3.4.1. HPTLC development 
 
Defatted crude extract of A. pubescens was obtained as follow: air-dried arial parts of the 
plant (300 g) were finely pulverized. The plant powder was extracted with 80% methanol 
(1:10, W:V) for 24 h, and evaporated under reduced pressure. The resulting residue was defat-
ted by liquid-liquid partitioning between 90% methanol (500 mL) and n-hexane (2 x 500 
mL). The defatted soluble extract was completely dried by rotary evaporator. For HPTLC-
EDA analysis, 20 mg of extract residue was dissolved in 1.0 mL methanol. Application vol-
ume was 2.0 µl that applied as a band of 8 mm length. Plates were developed as described in 
section 3.3.1 using mobile phase composed of CF : MeOH (9:2, V:V) and documented by the 
TLC Visualizer at UV 254 nm, 366 nm, and white light illumination (reflectance, transpar-
ence, and both modes together). Also, derivatization with p-anisaldehyde was performed as 
shown in section 3.3.1 followed by image-documentation. 
 
3.4.2. HPTLC-AChE inhibition assay 
 
The enzyme assay to determine the active inhibitor of AChE enzyme was done as de-
scribed in section 3.3.3. 
 
3.4.3. Active metabolites identification  
 
Defatted crude extract (1 g) was chromatographed on an open flash silica gel (230-400 
mesh) column eluted with dichloromethane : MeOH (90:10, V:V) yielding three fractions 
(F1-F3). Isolation of active metabolites was achieved by the preparative HPLC. Aliquots of 
100 µL injection volumes were used and the detector set at 210 nm. Isocratic elution with dif-
ferent methanol/water proportions allowed separation of three metabolites in pure form. 
Compound A1 (6 mg) & A2 (2 mg) were separated from F2 using 75% methanol in H2O as 
mobile phase. While subfraction F3, afforded compound A3 (5 mg) after elution with 55% 
methanol in H2O. Compounds  (A1 & A3) were dissolved in 600 µL metahnol-d4 for NMR 
(1D & 2D) measurements. Compound A2 was identified based on the HRMS and HRMS/MS 
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spectrometric data. Analysis of the ion fragments obtained through collision-induced dissoci-
ation permitted identification of A2. 
 
3.4.4. AChE inhibition equivalency calculation of compound A1-A3 
 
Using the free mode option of ATS-4, the isolated metabolites (A1-A3) were applied in 
triplicate, 20 µg/band each while, the standard reference, Riv, was applied at different con-
centration (0.5 - 14 µg/band). Then, the standardized AChE inhibition assay was followed as 
described. Densitometric analysis of the chromatograms was done using the TLC scanner set 
to fluorescence mode at 500 nm without optical filter. The calibration curve obtained from 
plotting Riv concentrations vs. peak areas and the regression equation was then generated. 
The results of AChE inhibition activity were expressed as bioactivity equivalent to Riv. 
 
3.5. HPTLC-GUS hyphenation  
 
3.5.1. Method development 
 
A method for rapid screening and determination of GUS inhibitors present as either pure 
forms or a part of complex mixtures was developed. The method based on the potential of 
GUS to hydrolyse X-Gluc substrate into 5-bromo-4-chloro-3-indol (fluorescent, colorless) 
and β-glucuronide units. The former unit undergoes further oxidation (fluorescent, colorless) 
with atmospheric oxygen followed by dimerization into the end products (non fluorescent, 
blue colored).  
 
3.5.2. Optimization and validation of the method 
 
Optimization of the method involved optimizing the detection wavelength, GUS concen-
tration, reaction time, and the impact of using plates with or without fluorescent indicator. 
Also, the method was validated in terms of LOD, linearity, and specificity.  
The current method used the up-to-date technology of TLC derivatization, i.e. piezoelectric 
spraying, achieved by TLC derivatizer. For determination of the optimal absorbance wave-
length of the background, the plate was scanned using the TLC scanner in absorbance mode 
(200 - 800 nm) while the white inhibition zone of the standard inhibitor, SL (1 µg/band), 
 
	 38	
served as a reference. The optimum detection wavelength obtained was used afterwards as a 
criterion for further optimization and validation studies, in which the plates were densitomet-
rically scanned in fluorescens mode. 
With regard to the GUS optimal concentration, enzyme solution (3.0 mL) at seven differ-
ent concentration levels (2 - 33 U/mL, i.e. 0.03 - 0.5 U/cm2 in phosphate buffer 0.1 M, pH 
7.0) with a fixed volume (1.5 mL) of X-Gluc (prepared as 2 mg/mL in deionized H2O) was 
used. Optimization of the reaction time involved incubation of the chromatogram at 37 ºC in 
a humid atmosphere ensured by placing the HPTLC plates in a wet well-closed plastic box 
for periods of 20, 40, and 60 min. Then, the plates were densitometrically scanned at the op-
timal wavelength in a fluorescens mode and peak areas of the inhibition zones of SL (1.0 µL, 
n = 3) were determined to obtain the optimal incubation time. The influence of using HPTLC 
plates with and without fluorescent on colorimetric detection was investigated.  
 
The LOD of GUS was determined using serial dilutions of the standard inhibitor SL (0.75 
- 2000 ng/band). LOD determined at a signal to noise (S/N) ratio of ≥ 3. Also, the linearity 
was examined by plotting the different SL concentrations vs. the peak areas of inhibition and 
the linear correlation equation was determined from the resulting curve. The specificity was 
studied by using a different substrate (2-naphthyl-β-D-glucopyranoside). 
 
3.5.3. Statistical analysis 
 
Statistical analyses were accomplished using Minitab 17® software. Collected data were 
subjected to analysis of variance (ANOVA) and means were compared through Fisher Pair-
wise Comparison (p  ≤  0.05). 
 
3.5.4. Verification of the method 
 
To verify the new method, two samples of botanical material were screened using the op-
timized workflow. The studied samples were P. boveana extract (as prepared in section 3.3.1) 
and SFLG. The SFLG sample was prepared by dissolving 250 mg of the flavonolignans 
powder in methanol (1:10, W:V), sonicated for 10 min, diluted with methanol (1:100, V/V), 




The optimized protocol for screening of GUS inhibitors in both test samples was applied as 
shown in Fig. 12. Both samples were known for their phyto-constituents with varied chemi-
cal properties, which demanded the use of different developing systems with variable eluting 
powers to separate their individual components. Hence, offered a good option to examine the 
influence of different mobile phase compositions on the behavior of the method. 
 
3.5.5. Active metabolites identification  
 
The active GUS inhibitors were determined under UV 254 and 366 light. For visualiza-
tion of the possibly non-UV absorbing inhibitors, plates were derivatized with NP/PEG and 
documented under 366 UV light. For P. boveana, active inhibitors were characterized by 
comparison with reference compounds previously isolated in section 3.3.4. While in SFLG, 
the active GUS inhibitors were identified by extensive HRMS and HRMS/MS analysis. In 
order to prevent the strong background signals and ion suppression from the formed inorgan-
ic salts (salt clusters) due to acidic mobile phase, pretreatment of the plates was carried out as 
described by Glavnik et al. (2017). The plates pretreatment step involved two pre-
developments of the plates, firstly with MeOH : FA (10:1, V/V) and secondly with acetoni-
trile : MeOH (2:1, V/V) with 20 min drying at 100 ºC after each development. Mass data was 
collected after elution of the targeted bands with HPTLC-MS interface. Acquisition was per-
formed in -ve mode polarity. Eluting solvent, mass range, capillary voltages, and source tem-
perature criteria were the same as in section 3.3.4. HR-MS/MS analysis was achieved with 
HR-MS2 scan mode acquisition. Collision energy was varied 10 - 50 V but finally 20 V was 































Fig. 12. Schematic representation of the verification study showing the optimized HPTLC-GUS inhi-

















3.6. HPLC-HRMS followed by EPI scanning for flavonoids profiling of P. 
boveana 
 
The experimental protocol for analysis of flavonoids content in P. boveana depended on 
LC-HRMS followed by tandem mass analysis of the glycoconjugated flavonoids through EPI 
scanning. The mobile phase used for HPLC separation was composed of acetonitrile as sol-
vent A and H2O (0.1% TFA) as solvent B. Flow rate was set to 0.25 mL/min and gradient 
elution was programmed as follow: 0 min (5% A), 5 min (5% A), 60 min (95% A), and 65 
min (95% A) with an injection volume of 15 µL. PDA detector was set at λ 254 nm. The 
mass data collected in a full scan mode and the spectrometer parameters included: ESI as an 
ion source in set to positive ion polarity, capillary voltage (3.8 kV), sheath gas (3.0 mL/min) 
and source temperature (310 ºC). 
For better understanding of the detailed structures of the flavonoids, the molecular mass of 
eluted metabolites was subjected to tandem mass analysis through the EPI scanning. The tri-
ple quadrupole mass spectrometer affected parent ion fragmentation through collision-
induced dissociation in the second RF-only quadrupole. The Q-TRAP spectrometer set to EPI 
scan mode and targeted molecular ion of metabolites were entered. ESI is the source of ioni-
zation in positive ion polarity. Nebulization gas (nitrogen) pressure 40 psi, drying gas (N2) 
flow 9 L/min and source temperature 350 ºC, capillary voltage at 4 kV. Flavonoid com-
pounds were tentatively identified based on analysis of their accurate molecular masses and 



















4.1. Biological evaluation and active metabolites identification of P. boveana  
(leaf) and P. veris (flower) 
 
4.1.1. HPTLC-antibacterial bioassay  
 
The antibacterial activity of middle polar extracts of P. boveana leaves and P. veris flow-
ers was evaluated by means of HPTLC-EDA approach. Two bacterial strains were used in 
this study, A. fischeri and B. subtilis. In A. fischeri bioassay, the bacterial inhibition was indi-
cated by the loss of the bacteria's endogenous luminescence, which could be easily spotted by 
observing the dark inhibition zones against the luminescent background. Detection of inhibi-
tory activity against B. subtilis detected as white zones against a purple background.  
For P. veris, the extract was applied in 2.0 µL & 1.0 µL for A. fischeri and B. subtilis, respec-
tively. Two metabolites (Pv1 & Pv2) displayed inhibitory activity against both bacterial 
                                                                                 4. Results 
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strains (Fig. 13A). In P. boveana, the extract was applied as 1.0 µl (for A. fischeri) and 0.5 
µL (for B. subtilis). The results (Fig. 13B) revealed that four metabolites (Pb1 - Pb4) were 
the most active against A. fischeri; only two (Pb1 & Pb2) were found active against B. sub-
tilis.  
 
4.1.2. HPTLC-AChE/BChE inhibition assay  
 
The possible inhibitory activity of both extracts towards the ChE enzymes family was al-
so investigated. Two enzymes, AChE and BChE were used; zones of inhibition manifested 
by their white bands against the purple background of the formed formazan. The results of 
the assay were found very comparable to those obtained for the antibacterial investigation. 
Compounds (Pv1 & Pv2) in P. veris extract inhibited both enzymes (Fig. 13A). In P. bo-
veana, compounds (Pb1 - Pb4) inhibited BChE, while AChE has been inhibited only by Pb1 
& Pb2 (Fig. 13B).    
  
Fig. 13. Chromatograms of P. veris 
flower extract (A) and P. boveana leaf 
extract (B) at UV 254 and 366 nm (1 
and 2), after p-anisaldehyde derivati-
sation at white light illumination and 
UV 366 nm (3 and 4) and respective 
A. fischeri, B. subtilis, acetyl and bu-












4.1.3. Active metabolites identification  
 
HRMS analysis  
 
Identification of the bioactive metabolites in both extracts was achieved by first collecting 
their HRMS data; this allowed for a tentative structural determination of the active com-
pounds. Acquisition in -ve ESI mode was found optimum for P. veris compounds, where the 
deprotonated [M-H]- ion peaks were predominant. In contrast, +ve ESI was better for P. bo-
veana compounds, such that the sodium adducts [M+Na]+ were obtained. 
The MS data suggested the molecular formula of Pv1 as C18H32O2 and that of Pv2 as 
C18H30O2, as revealed from their molecular ion peaks at m/z 279.2329 (calculated 279.2329 
for [M-H]-) and m/z 277.2174 (calculated 277.2173 for [M-H]-), respectively (Fig. 14). These 
mass values as well as the chromatographic characteristics on the HPTLC plate after derivati-
zation were consistent with those of linoleic and linolenic acids (Kurata et al. 2005; Krüzselyi 
et al. 2016). Thus, the structure of Pv1 was determined as linoleic acid (C18:2) and Pv2 as 
linolenic acid (C18:3).   







Fig. 14. Negative ion HPTLC-ESI-HRMS spectra obtained for compounds Pv1 and Pv2 and their 
structures  
Compounds (Pb1-Pb4) were also assigned based on their HRMS measurements. The com-
pounds showed base peaks corresponding to [M+Na]+ and [2M+Na]+ (Fig. 15), thus, afford-
ing a high formula prediction information. The molecular ion peak of Pb1 at m/z 245.0570 
suggested the molecular formula as C15H10O2 (calculated 245.0573 for [M+Na]+). This mass 
information is consistent with the prevailing lipophilic flavonoid exists in most of the Primu-
la plants, which is unsubstituted flavone (Colombo et al. 2017). So, the structure of Pb1 was 
tentatively assigned as an unsubstituted flavone. Hereafter, identification of the subsequent 
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metabolites was based on deduction of their mass differences from Pb1. For the Pb2 zone, 
the sodium adduct of the ion peak at m/z 275.0675 [M+Na]+ (calculated 275.0679), which is 
30 Da higher than Pb1, suggested C16H12O3 as the molecular formula of Pb2 and thus its 
structure as methoxyflavone. Similarly, Pb3 showed an ion peak at m/z 261.0520, 16 Da 
more than Pb1, indicated its molecular formula as C15H10O3 (calculated m/z 261.0522 for 
[M+Na]+ ), hence, Pb3 was deduced to be hydroxyflavone. Compound Pb4 gave an ion peak 
at m/z 365.0990 corresponding to a molecular formula C19H18O6 (calculated m/z 365.0996 for 













Fig. 15. Positive ion HPTLC-ESI-HRMS spectra obtained for compounds Pb1 - Pb4. 
 
NMR measurements of (P1-Pb4) 
 
Despite the partial assignment of the active metabolites in P. boveana extract (Pb1-Pb4), 
their full structure elucidation of Pb1-Pb4 is not completely resolved since the exact posi-
tions of the substituents (OH or OMe) have not concluded yet. Therefore, preparative isola-
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tion of these active compounds was done for further NMR analysis. Successfully, the four 
metabolites were obtained in pure forms by chromatographic resolution of the total extract by 
means of the preparative HPLC over RP-column with an isocratic elution with 60% methanol 
in water. All compounds, Pb1 (3.9 mg), Pb2 (2.6 mg), Pb3 (1.5 mg), and Pb4 (2.1 mg) were 
separately subjected to 1H NMR analysis; spectra are shown in Fig. 16. 
Compound Pb1: UV (max: 251 nm) in the 1H NMR spectrum, the characteristic H-3 of fla-
vone was observed at δH  6.80 as singlet. Signals typical for unsubstituted 
ring A of flavone were assigned at δH 8.11 (ddd, J = 0.4, 1.6, 8.0, H-5); δH 
7.40 (ddd, J = 1.1, 7.1, 8.0, H-6); δH 7.70 (ddd, J = 1.6, 7.1, 8.5, H-7); δH 
7.60 (ddd, J = 0.4, 1.1, 8.5, H-8). Also, two peaks integrating for two pro-
tons each at δH 8.02 (dd, J = 1.5, 7.7, H-2' & H-6') and δH 7.51 (m, H-3' & 
H-5') together with the presence of a multiplet proton resonates at δH 7.54 
(H-4') were detected. These findings along with the collected HRMS data 
and literature values' comparison (Budzianowski et al. 2005) confirmed the 
structure of Pb1 as unsubstituted flavone. 
Compound Pb2 UV (max: 253 nm) & Pb3 UV (max: 251 nm): 1H NMR spectra of both 
compounds have unambiguously confirmed that ring A remained unsubsti-
tuted in both structures. However, the spectrum showed a quite different 
pattern of ring B signals, implying that a substitution is present. In 1H NMR 
spectrum of Pb2, four aromatic protons were observed at δH 7.21 (dd, J = 
1.0, 8.4), δH 7.50 (ddd, J = 1.7, 7.4, 8.4), 7.13 (ddd, J = 1.0, 7.4, 7.8), and 
7.95 (dd, J = 1.7, 7.8) ascribable to H-3', H-4', H-5', and H-6', respectively. 
Also, in 1H NMR spectrum of Pb3, the four aromatic protons of ring B 
were observed at δH 7.0 (dd, J = 1.1, 7.1), δH 7.30 (ddd, J = 1.7, 7.1, 8.3), 
6.90 (ddd, J = 1.1, 8.0, 8.3), and 7.95 (dd, J = 1.7, 8.0) ascribable to H-3', 
H-4', H-5', and H-6', respectively. These NMR findings were found con-
sistent with those reported in literature for the same metabolites (Blaskó et 
al. 1988; Moon et al. 1982), pointing out that compound Pb2 is a 2'-
methoxyflavone and Pb3 is a 2'-hydroxyflavone. 
Compound Pb4: UV (max: 325, 266, 233 nm) the spin-spin multiplicity of protons of com-
pound Pb4 were found rather simple. The 1H NMR spectrum showed two 
sets of ortho-coupled protons at δH 7.52 (d, J = 9.3, H-7) & δH 7.31 (d, J = 
9.3, H-8). It also revealed the presence of a signal at δH 6.70 (d, J = 8.5) in-
tegrates for two protons H-3' & H-5' with ortho coupling as well as another 
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signal at δH 7.44 (t, J = 8.5) due to H-4'. These spectral observations re-
vealed that the four methoxy groups at δH 3.92 (3H, s), δH 3.87 (3H, s), and 
δH 3.79 (6H, s) were positioned at C-5, C-6, C-2' and C-6', respectively. 
From these spectroscopic views, Compound Pb4 has been assigned as 
5,6,2',6'-tetramethoxyflavone or as it is commonly known, zapotin, which 
previously has been found in P. veris (Budzianowski et al. 2005).   
 
    















Fig. 16. 1H NMR spectra and structures of compounds Pb1-Pb4. 
 
4.1.4.  AChE inhibition equivalency calculation of Pb1 
 
AChE inhibition equivalency calculation of compound Pb1 in the crude extract of P. bo-
veana was performed using the HPTLC-densitometric analysis as described in section 
(3.3.5). The inhibitory activity of the studied metabolite was compared to the activity exhibit-
ed by a reference standard inhibitor, Riv (Fig. 18). The peak areas obtained by densitometric 
analysis of the inhibition zones of the serially diluted Riv (1 - 10 µg/band) (Fig. 17) were 














Fig. 17. AChE inhibition equivalency experiment: AChE autogram of P. boveana extract (1 g/10 mL, 
0.5 and 0.1 µL applied, three replicates of 50 and 10 µg/band) with standard Riv applied as 
track pattern after development (1 mg/mL, 1-10 µL applied, 1-10 µg/band) and respective 
densitogram (absorbance measurement) at 500 nm obtained by inverse scanning. 
The obtained curve showed a linear correlation within the applied range of Riv. The linear 
equation was generated and determined as y = 621.6 x + 2721, where y is the peak area and x 
is the concentration of Riv in µg/band (Appendix 1). The results showed that the AChE in-
hibitory activity of Pb1 contained in the applied amount of the extract (0.1µL extract); in 
other words, in 10 µg leaf powder was biologically equivalent to a calculated amount of 4.5 
µg Riv. Meaning, the unsubstituted flavone contained in P. boveana leaf extract powder 














4.2. Biological evaluation and active metabolites identification of A. pu-
bescens  
 
4.2.1. HPTLC-AChE inhibition assay 
 
With the aim of studying the AChE inhibitory activity of the iridoids constituents of A. 
pubescens, the defatted crude extract was analyzed using the HPTLC-EDA method. The re-
sults revealed the presence of three active inhibition zones corresponding to three separately 











Fig. 19. HPTLC chromatograms of the A. pubescens extract at UV 254 (A), UV 366 nm (B), white 
light (C) and UV 366 nm after p-anisaldehyde derivatization (D) as well as HPTLC autogram 
after the acetylcholinesterase assay (E) and the determined structures of the isolated bioactive 
metabolites A1 - A3. 
4.2.2. Active metabolites identification  
 
Structural elucidation of the active metabolites was also achieved. Compounds (A1 & 
A3) were separated through successive preparative HPLC separations and identified based on 
their HRMS and 1D & 2D NMR spectroscopic data while, A2 was structurally identified 








Table 3: 1H and 13C NMR data of the compounds A1 and A3 














1	 5.3	d	(7.1)	 94.0	 6'-O-Cinnamoyl	 1	 5.7	d	(2.5)	 92.6	 6-O-	foliamenthoyl	
3	 6.3	d	(6.3)	 141.8	 1"	 -	 167.0	 3	 6.5	d	(6.5)	 144.7	 1"	 -	 166.9	
4	 4.9	d	(6.3)	 106.3	 2"	 6.6	d	(16.0)	 117.4	 4	 5.4	d	(6.5)	 101.5	 2"	 -	 127.4	
5	 -	 73.3	 3"	 7.7	d	(16.0)	 145.6	 5	 -	 79.5	 3"	 6.6	td	(7.3,	1.4)	 142.1	
6	 5.0	d	(1.8)	 78.4	 4"	 -	 134.2	 6	 5.1	d	(2.8)	 75.3	 4"	 2.2	m	 27.01	
7	 3.5	d	(1.8)	 62.7	 5"	&	9"	 7.5	m	 128.1	 7	 3.5	d	(2.8)	 63.5	 5"	 2.1	m	 30.36	
8	 -	 62.9	 6"	&	8"	 7.3	m	 128.6	 8	 -	 63.5	 6"	 -	 137.1	
9	 2.4	d	(7.1)	 52.2	 7"	 7.3	m	 130.3	 9	 2.8	brs	 49.2	 7"	 5.3	dd	(6.8,	1.4)	 125.32	
10	 1.4	s	 16.2	 6-O-Cinnamoyl	 	 10	 1.4	s	 15.2	 8"	 4.03	d	(6.8)	 57.8	
Glucose	 	 1'"	 -	 166.5	 Glucose		 	 9"	 1.7	*	 11.0	
1'	 4.7	d	(8.0)	 98.4	 2'"	 6.6	d	(16.0)	 117.0	 1'	 4.6	d	(7.8)	 99.5	 10"	 1.7	*	 22.31	
2'	 3.2	m	 73.0	 3'"	 7.7	d	(16.0)	 145.3	 2'	 3.18	dd	(9.1,	7.8)	 73.6	 5-O-foliamenthoyl	
3'	 3.4	m		 76.0	 4'"	 -	 134.4	 3'	 3.3	m	 76.9	 1"'	 -	 166.6	
4'	 3.3	m	 70.0	 5'"	&	9'"	 7.5	m	 128.1	 4'	 3.2	m	 70.2	 2"'	 -	 128.1	
5'	 3.5	m	 74.0	 6'"	&	8'"	 7.3	m	 128.6	 5'	 3.3	m	 77.1	 3"'	 6.7	td	(7.3,	1.4)	 142.3	
6'a	 4.5	dd	(12.0,	2.5)	 63.07	 7'"	 7.3	m	 130.3	 6'a	 3.6	dd	(12.0,	6.3)	 61.5	 4"'	 2.2	m	 27.07	
6'b	 4.4	dd	(12.0,	6.0)	 	 	 	 	 6'b	 3.9	dd	(12.0,	2.1)	 	 5"'	 2.1	m	 30.38	
	 	 	 	 	 	 	 	 	 6"'	 -	 137.3	
	 	 	 	 	 	 	 	 	 7"'	 5.4	dd	(6.8,	1.4)	 125.34	
	 	 	 	 	 	 	 	 	 8"'	 4.06	d	(6.8)	 57.9	
	 	 	 	 	 	 	 	 	 9"'	 1.7	*	 11.2	











Fig. 20. Key 1H-13C HMBC correlations of compounds A1 and A3. 
 
Compound A1 (6 mg) was isolated from the subfraction F2 after isocratic elution with 75 % 
MeOH in H2O as yellowish powder. The molecular formula of A1 was deduced as C33H34O12 
from the observed HRESIMS molecular ion peak at m/z 645.1952 [M+Na]+ (Calculated 
645.1942 for C33H34O12Na+) (Appendix 2). 1H and 13C NMR spectral data of A1 (Table 3, 
Appendix 3 & 4) suggested the structure of A1 as antirrhinoside-based iridoids. This was 
attributed to the assignment of the acetalic methine at δH 5.3 (d, J = 7.1 Hz, H-1)/δC 93.8 as 
well as the two doublet vinylic protons at δH 6.3 (d, J = 6.3 Hz, H-3) and δH 4.9 (d, J = 6.3 




presence of aliphatic methine at δH 3.5 (d, J = 1.8 Hz, H-7)/δC 62.7 (C-7) as well as quater-
nary carbon at δC 62.9 (C-8), which are indicatives to the 7, 8-epoxy linkage in the cyclopen-
tan ring of the antirrhinoside.  As antirrhinoside iridoids are naturally having the sugar unit 
positioned at C-1, this was unambiguously observed by allocating the cross correlation be-
tween the anomeric proton of the β-glucopyranoside at δH 4.7 (d, J = 8.0 Hz, H-1') and C-1 
(δC 93.8). The 1H-1H COSY (Appendix 5) has also supported these assumptions, where cou-
plings between H-3/H-4; H-6/H-7; H-1/H-9 have been observed. The NMR spectral data 
have also showed signals characteristic to two cinnamoyl units. The two carbonyl esters of 
the acyl groups were observed at (δC 167.0, C-1" & δC 166.5, C-1"'). Furthermore, the trans 
configuration of the olefinic protons was confirmed by inspecting their spin-spin coupling 
constants (δH 6.6, d, J = 16.0 Hz, H-2" & H-2"' and δH 7.7, d, J = 16.0 Hz, H-3" & H-3"'). 
Thus, the structure of A1 has been partially determined to possess two cinnamoyl moieties 
attached to the basic antirrhinoside structure. The positions of these two acyl groups was con-
firmed by assigning the HMBC correlations (Fig. 20, Appendix 7) and were found that one 
cinnamoyl is attached to C-6 and the second to C-6''. Naturally occurring antirrhinosides have 
their H-1, H-6, H-7, and 3H-10 protons in α-orientation. This also implied to A1 in which the 
coupling constants JH-1, H-9 = 7.1 Hz and JH-6, H-7 = 1.8 Hz are in agreement with those reported 
for antirrhinoside (Handjieva et al. 1993; Beninger et al. 2007). Based on this analysis, the 
structure of A1 was identified as 6-O, 6'-O di-trans-cinnamoyl-antirrhinoside (Fig. 19). To 
our knowledge, compound A1 is herein described for the first time. 
 
Compound A2: was isolated from the subfraction F2 after isocratic elution with 75 % 
MeOH in H2O as a yellowish brown oil. The molecular formula of A2 was deduced as 
C34H42O13 from the observed HRMS molecular ion peak at m/z 681.2518 [M+Na]+ (Calculat-
ed 681.2517 for C33H34O12Na+). Initial MS data analysis suggested the structure of A2 as 6-
O-foliamenthoyl-(6ꞌ-O-cinnamoyl)-antirrhinoside, an iridoid glucoside which previously iso-
lated from the same plant (Mahran et al. 2018). Further confirmation of the structure was car-
ried out through extensive analysis of the tandem mass spectrum (Fig. 21). The obtained 
fragment ions indicated successive loss/cleavage of the attached acyl and glucosyl moieties. 
Mass errors were up to only 1.1 ppm, proofing our interpretation for the fragments' structure. 
Hence, the structure of A2 was described as 6-O-foliamenthoyl-(6ꞌ-O-cinnamoyl)-


























Fig. 21. HRMS/MS spectrum of compound A2 (A) and detailed structural fragmentation pathway (B)  
(foliamenthoic acid, FA; cinnamic acid, CA; glucose, Glc) 
 
 
Compound 3: was isolated from subfraction F3 after isocratic elution with 55 % MeOH in 
H2O as a faint yellowish powder. The molecular formula of A3 was deduced as C35H50O14 
from the observed HRESIMS molecular ion peak at m/z 717.3094 [M+Na]+ (Calculated 
717.3093 for C33H34O12Na+) (Appendix 8). 1H, 13C, and HSQC NMR spectra of A3 (Table 3 
& Appendix 9, 10, 12) showed signals referred that the antirrhinoside nucleus is also embed-
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ded within the structure. The resonances corresponding to the acetalic methine δH 5.7 (d, J = 
2.5 Hz, H-1)/δC 92.6; vinylic methines at δH 6.5 (d, J = 6.5 Hz, H-3)/ δC 144.7 and δH 5.4 (d, J 
= 6.5 Hz, H-4)/δC 101.5 were clearly assigned. When compared to iridoids previously report-
ed for the genus, spectral values of A3 demonstrated a close resemblance to those of 6-O-
foliamenthoyl-antirrhinoside (Dawidar et al. 1989). The characteristic differences were that 
A3 displayed signals due to additional 10 carbon atoms along with a downfield shift of C-5. 
Meaning, A3 should include a second monoterpene unit in its structure, which was proved by 
observing a second set of protons and carbons of additional foliamenthoyl unit. With the help 
of the HMBC data (Fig. 20, Appendix 13), the position of the first foliamenthoyl unit was 
defined at C-6 whereas, the second was determined to be attached to C-5 as indicated form 
the remarkable downfield shift of C-5 (δC 79.5, normally ≈ 73.3). As in A1, the sugar occu-
pied the C-1 position with β-orientation. Also, JH-6, H-7 = 2.8 Hz confirmed their α-orientation 
which further established through the NOESY analysis (Appendix 14). NOESY cross peaks 
between H-6/H-7; H-1/H-10; H-7/H-10 proved their α-configuration. Thus, compound A3 
was structurally identified as 5-O, 6-O difoliamenthoyl-antirrhinoside (Fig. 19), and this is 
also reported here as a new isolated natural compound. 
 
4.2.3. AChE inhibition equivalency calculation of compounds (A1 - A3) 
 
The equivalency experiment was performed using the free mode application of 20 
µg/band of each compound as well as serial dilutions (0.5 - 14 µg/band) of the standard en-
zyme inhibitor, Riv. The inhibitory zones were densitometrically measured (Fig. 22 A and 
B). The curve showed a linear range within the range of 1 - 8 µg/band of Riv. The regression 
equation obtained from plotting the Riv concentration vs. the peak area was y = 404.7x + 
2180, where y is the peak area of the inhibition zone and x is the amount of Riv. Compound 
A1 showed inhibitory activity that turned out to be equivalent to 1.5 µg of Riv. Compound 
A2 showed inhibitory activity equivalent to 5.9 µg Riv. On the other hand, the applied 
amount of Compound A3 was found to be below the limit of quantitation of the given equa-
tion. Noteworthy, Riv as 200 ng/band is still detectable following the described HPTLC-






















Fig. 22. HPTLC autogram after AChE assay (A) and densitometric fluorescence measurement at 500 
nm (B) of compounds A1 - A3 (20 µg/band, n = 3) as well as rivastigmine tartrate (0.5 - 14 












4.3. HPTLC-GUS inhibition assay hyphenation 
 
The aim of this experiment was to transfer the GUS inhibition assay to HPTLC. Therefore, 
the individual inhibition activity of each component exist in a mixture could be directly eval-
uated after their HPTLC chromatographic separation. The method made use of the potential 
of GUS to hydrolyze X-Gluc into a colored end product and hence, inhibitors could be easily 
detected as a white zones. 
  




The background was scanned within the range of 200 - 800 nm in order to obtain the op-
timum absorption wavelength. The white inhibition zone of SL served as a reference. The 
obtained spectrum showed that the background exhibits several absorption maxima at 259, 
306, and 353. Also, it showed absorption ranging from 610 - 650 nm (Fig. 23). Statistical 
analysis showed no significant difference between peak areas of inhibition zones (n = 3) col-
lected at 612 and 650 nm. So, any of these wavelengths could be used as a colorimetric detec-
tion wavelength in densitometric analysis. 









Fig. 23. UV/Vis spectrum (200 - 800 nm) of the autogram background: the white inhibition zone of 
SL served as a reference. 
GUS concentration, reaction time, and effect of fluorescent indicator 
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Seven different concentrations of the GUS solution (2 - 33 U/mL, i.e. 0.03 - 0.5 U/cm2) 
were applied with 1.5 mL X-Gluc solution (2 mg/mL, i.e. 22.5 µM/cm2). The autograms, af-
ter assay application, were densitometrically scanned at λ 612 nm (Fig. 24A). The statistical 
analysis showed that GUS applied as 3.0 mL of 25 U/mL (i.e. 0.375 U/cm2) was the optimum 
GUS concentration. The optimum reaction time has been inspected initially over a three time 
levels (20, 40, and 60 min) (Fig. 24B) employing the optimum GUS concentration (3.0 mL of 
25 U/mL solution). The peak areas of the SL inhibitory zones were collected at 612 nm (n = 
3). Sixty minutes reaction time afforded the highest peak areas. However, shorter reaction 
times still useable for visual detection but the background/spot contrast would be weaker. 
Another attempt was done to examine a longer duration time (120 min) was performed. Alt-
hough a longer reaction time of, i.e. 120 min was statistically (p ≤ 0.05) still more significant, 
it was decided against, for the sake of a shorter workflow and 60 min was found as a reason-
able time. The impact of using HPTLC plates with or without fluorescent indicator on the 
colorimetric detection has been also investigated. Plates with fluorescent indicator afforded 












Fig. 24. Effect of GUS concentration (A), incubation time (B), and fluorescent indicator (C) on peak 
areas of the standard inhibitor, SL (1 mg/mL, applied as 1 µg/band, n = 3). Areas were rec-




4.3.2. Method validation 
 
The developed method has been validated in terms of the lowest concentration of SL the 
produce S/N ≥ 3, linearity, and specificity. Serial dilutions of the SL solution (0.75 - 2000 
ng/band, n = 3) were applied (Fig. 25, left), the peak areas were measured at 612 nm. The 
lowest concentration applied in this study and found to give S/N value ≥ 3 was corresponding 
to 62 ng/band (S/N = 4). Regression line was established within the range (62 - 1000 
ng/band) where the results fit well to the second order polynomial function (Fig. 25, right), y 
= - 0.004x2 + 8.400x + 22.69 with R2 of 0.993. Furthermore, a specificity experiment was 
done in order to confirm the specific affinity of GUS to the used substrate. In this experiment 
a different substrate was used that has another sugar (β-glucose); the results revealed that the 










Fig. 25. Left: Densitometric analysis of SL (0.75 - 2000 ng/band) applied as band pattern showing 
that 62 ng/band is the lowest concentration used in this experiment and could be detected vis-
ually (Also, proofs the calculated S/N ≥ 3). Right: the standard calibration curve for SL over 
the range (62 - 1000 ng/band). 
4.3.3. Method verification 
 
In order to verify the developed method, the optimized assay was performed on two dif-
ferent botanical samples, P. boveana leaves extract & SFLG extract. The assay was carried 





HPTLC-GUS-HRMS analysis of P. boveana  
Two active inhibitors, Pb1 & Pb2, (Fig. 26) were detected in P. boveana extract. Active 
metabolites were detected both fluorometrically (under UV 366 nm) as well as colorimetri-
cally (under white light), proving the dual readout detection of the developed hyphenation. 
These active metabolites were previously elucidated as unsubstituted flavone and 2'-methoxy 
flavone (section 4.1.3).  







Fig. 26. A) HPTLC-GUS hyphenation for detection of the enzyme inhibitors in P. boveana extract 
applied as 0.5 µL. Chromatogram under UV 254 nm (1); UV 366nm (2); after NP/PEG deri-
vatization at 366 nm (3); after assay application at 366 nm (4) and under white light (5). B) 
Confirmation of the active inhibitors by co-chromatographic elution of the P. boveana extract 
with reference compounds in 1 µL/band each, detected under UV 254 and 366 nm light. 
	
HPTLC-GUS-HRESIMS/MS analysis of SFLG 
 
The flavonolignan constituents of silymarin were separated using two MP (Fig. 27 A and 
B), MP1 (CF : Acet : FA, 75:16.5:8.5, V/V/V)  & MP2 (Toluene : EtOAc : FA, 9:6:0.4, 
V/V/V). Both systems contained FA but in different proportions, which also permitted moni-
toring the assay results under other variable chromatographic conditions than those men-
tioned with P. boveana in the later experiment. Apparently, one major band (SFLG1) has 
demonstrated a remarkable inhibition to GUS. With the use of MP1, the assay was impaired 
in non-neutralized plates, but worked well when the plates subjected to neutralization with 
phosphate buffer at pH 7.8. So, the neutralization step seems essential when FA intended to 
be used at a higher concentration. By using MP2 as a mobile phase, the assay (in plates with 
and without pre-neutralization) was still able to provide detection information, indicating that 
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the assay could the FA addition until its concentration in the mobile phase increases to a limit 












Fig. 27. HPTLC-GUS hyphenation for detection of the enzyme inhibitors in SFLG extract applied as 
1.0 µL using two different developing systems, MP1 (A) and MP2 (B), as well as mass analy-
sis, HRMS (C) and HRMS/MS at collision energy of 20 V (D) of the active inhibitor, 
SFLG1.1, Chromatogram at UV 254 nm; 2, at UV 366 nm; 3, after NP/PEG derivatization at 
366 nm; 4, fluorometric detection after assay application (with neutralization); 5, colorimetric 
detection (with neutralization); 6, colorimetric detection (without neutralization).  
 
Characterization of the active metabolites was based on HRMS/MS analysis. The mo-
lecular formula of SFLG1 was deduced as C25H22O10 as revealed form the observed ion peak 
at m/z 481.11459 (calculated 481.11402 for [M-H]-) (Fig. 27C). Distinguishing the individu-
al flavonolignans mixture of silymarin through MS analysis is always a challenge analysis as 
they share the same molecular masses of 482 Da and almost comparable fragmentation be-
havior. Recent studies have focused on MS/MS-based characterization of major components 
in SFLG and set some criteria in order to facilitate their rapid identification. These criteria 
depended mainly on the presence of some diagnostic peaks as well as their relative abun-
dance at a defined CE (Kuki et al. 2012a, 2012b; Brinda et al. 2012). The MS2 scan of 
SFLG1 acquired at six different levels of CE (10, 20, 25, 30, 40, and 50 V) is displayed in 






fragment ions as the energy increases, until CE of 20 V is attained, at which the optimum 
fragmentation pattern with multiple ion peaks is obtained. At higher energies 25-50 V, only 
stable ions are visible. In MS2 spectrum of SFLG1 collected at CE of 20 V (Fig. 27 D), the 
base peak at m/z 125 followed by an ion at m/z 179 are the most intense peaks; the ratio of 
463/453 ions intensities is more than 1; fragment ion at m/z 301 is almost 1 or less; the pres-
ence of fragment ions at m/z 355 & 433, are all hallmarks of silychristin flavonolignan. 


























4.4. HPLC-HRMS and EPI analysis for identification of flavonoid constit-
uents in P. boveana leaves 
In this experiment, the HPLC coupled to HRMS followed by MS/MS (represented by EPI 
scan type) analysis were pursued in order to tentatively characterize the flavonoid constitu-
ents of P. boveana. The accurate molecular masses obtained from the HRMS analysis (Ap-
pendix 17) were used as entry points for collecting the CID MS/MS data (Appendix 18). A 








Fig. 28. HPLC chromatogram of P. boveana hydro-alcoholic extract at UV 254 nm 
 
The recognized compounds covered a wide range of flavonoids metabolites; in harmony with 
many previously studied Primula sp., P. boveana has demonstrated a considerable number of 
polar as well as nonpolar flavonoids. Initial determination of the elemental composition of 
each eluted peak depended on the LC-HRMS data with a maximum mass error of 0.7 ppm. 
Then, the low-energy CID mediated through EPI scan analysis of [M+H]+ ions has afforded a 
comprehensive fragmentation pattern through which the characterization of the molecular 
subunits of the flavonoids glycoconjugates was accomplished. 
Glycoconjugated flavonoids  
Thirteen compounds (1 - 13) in the extract were determined as glycoconjugated flavo-
noids. These compounds represented several aglycone structures that are linked to varying 
sugar compositions (mono-, di-, and tri-saccharides); three out of these thirteen compounds 
have showed a conjugation with the organic acid, malonate. The aglycone part of these me-
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tabolites has also showed different degree of hydroxylation (mono-, di-, tri-, tetra-, and penta-
hydroxylated flavone). Glycoconjugates of kaempferol and quercetin were the most recog-
nized flavonoid glycosides present in Primula plants (Colombo et al. 2017; Apel et al. 2017). 
Henceforth, the compounds in the extract that have been assigned to contain aglycones with 
four or five OH groups were defined here as kaempferol and quercetin derivatives, respec-
tively. Diagnostic ion peaks corresponding to sequential loss of one or more glycosyl and/or 
malonate moieties made it plausible to determine the size of the glycone as well as the agly-
cone parts. However, the compound profiling based solely on MS analysis sometimes en-
counter difficulties in assigning the conjugation sites between the aglycones and glycones 
units, hence, a tentative assignment of the compounds is proposed. The common mass loses 
detected in this study with their corresponding identity were as follow: loss of 162, 146, 308, 
and 84 Da, indicated the presence of hexose, deoxyhexose (rhamnose), hexose-deoxyhexose, 
and malonyl moieties, respectively (Cuyckens and Claeys 2004). Compounds (9, 11 - 13) 
demonstrated spectacular mass features that are distinct from those previously known for the 
Primula are herein described in details.  
Compound 9 showed a molecular ion peak in Fig. 29A (left) at m/z 401.1233 corresponding 
to the molecular formula of C21H20O8 (calculated 401.1230 for [M+H]+). Flavonoid with such 
molecular mass has not been previously described in genus Primula. The structure of 9 
showed a simple fragmentation pattern as shown in Fig. 29A (right). The EPI spectrum 
showed a single product ion (due to loss of 162 Da) at m/z 239 [M-hexoside+H]+, indicating 
the structure of the aglycone part as monohydroxyflavone. So, compound 9 has been tenta-
tively identified as monohydroxyflavone hexoside. 
The malonylated flavonoid glycosides were identified as: dihydroxyflavone-malonylhexoside 
(11), monohydroxyflavone-malonylhexoside (12), and dihydroxyflavone-malonylhexoside 
isomer (13). Compound 11 showed a protonated ion peak at m/z 503.1185 (Fig. 29B, left). 
EPI analysis of 11 showed the diagnostic peaks at m/z 459 and 417 suggested the loss of CO2 
and malonyl groups, respectively (Fig. 29B, right) (Cuyckens and Claeys 2004). The transi-
tion from the ion peak at m/z 459 to the ion peak at m/z 255 revealed a loss of hexoside, leav-
ing the characteristic aglycone peak at m/z 255 [M-malonylhexose+H]+, which is here de-
fined as a dihydroxyflavone. On the basis of the mass analysis, compound 11 has been tenta-
tively characterized as dihydroxyflavone-malonylhexoside. Compound 12 showed a molecu-
lar ion peak at m/z 487.1236 (Fig. 29C, left), which is 16 mass units less than 11 indicating 
that 12 has one OH group less. In the EPI spectrum (Fig. 29C, right), 12 showed signal 
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peaks at m/z 443 and 401 refereeing to the loss CO2 and malonyl units, respectively. EPI of 
12 showed also a peak at m/z 239 corresponding to [M-malonylhexose+H]+ which is the 
aglycone part and defined as monohydroxyflavone. Therefore, compound 12 has been deter-
mined as monohydroxyflavone-malonylhexoside. Compound 13 displayed a similar molecu-
lar mass as of 11, so it has been assigned as an isomer of 11. Malonylated flavonoids have 
not previously described in Primula and here is the first occurrence of such phyto-
constituents in the genus. 






















1 19.9 Quercetin-trihexoside C33H40O22 789.2088 789.2084 - 0.5 627,487, 465, 
325, 303 
2 20.6 Quercetin-hexoside-dirhamnoside C33H40O20 757.2189 757.2185 - 0.5 611, 465, 303 
3 21.0 Kaempferol-trihexoside C33H40O21 773.2138 773.2134 - 0.5 611, 287 
4 21.4 Kaempferol-hexoside-dirhamnoside C33H40O19 741.2239 741.2236 - 0.4 595, 287 
5 22.1 Quercetin-hexoside-rhamnoside C27H30O16 611.1603 611.1606 - 0.4 303 
6 22.9 kaempferol-hexoside-rhamnoside C27H30O15 595.1658 595.1657 - 0.1 287 
7 23.4 kaempferol-hexoside-rhamnoside 
(isomer) 
C27H30O15 595.1658 595.1657 - 0.1 287 
8 24.6 Dihydroxy flavone-O-hexoside C21H20O9 417.1180 417.1180   0.0 255 
9 25.5 Flavone-O-hexoside C21H20O8 401.1233 401.1230 - 0.7 239 
10 26.5 Dihydroxy flavone-hexoside C21H20O9 417.1180 417.1180   0.0 255 
11 26.7 Dihydroxy flavone-
malonylhexoside 
C24H22O12 503.1186 503.1184 - 0.3 459, 417, 255 
12 27.4 Flavone-O-malonylhexoside C24H22O11 487.1236 487.1234 - 0.4 443, 401, 239 
13 27.5 Dihydroxyflavone- malonylhexo-
side 
C24H22O12 503.1185 503.1184 - 0.2 459, 417, 255 
14 29.0 Dihydroxyflavone C15H10O4 255.0652 255.0651 - 0.3 -- 
15 31.3 Trimethoxy-monohydroxyflavone C18H16O6 329.1020 329.1019 - 0.3 -- 
16 32.9 Monohydroxy-methoxyflavone C16H12O4 269.0808 269.0808   0.0 -- 
17 34.6 2'-Hydroxy flavone C15H10O3 239.0703 239.0702 - 0.4 -- 
18 35.8 Trimethoxy flavone C18H16O5 313.1071 313.1070 - 0.3 -- 
19 36.5 5,6,2',6'Tetramethoxyflavone C19H18O6 343.1176 343.1176   0.0 -- 
20 37.1 Dihydroxy-methoxthy flavone C16H12O5 285.0758 285.0757 - 0.3 -- 
21 39.5 Unsubstituted flavone  C15H10O2 223.0753 223.0753   0.0 -- 
22 40.7 2'-Methoxyflavone C16H12O3 253.0859 253.0859   0.0 -- 
23 43.7 Dimethoxy-hydroxyflavone C17H14O5 299.0914 299.0914   0.0 -- 
24 44.8 Dimethoxy-hydroxyflavone C17H14O5 299.0914 299.0914   0.0 -- 
25 46.1 Monohydroxy-methoxyflavone 
(isomer) 
























Fig. 29. HRESIMS spectra of compound 9 (A), 11 (B) and 12 (C) (left); the corresponding EPI spec-
tra of each molecular ion peak (right). 
Flavonoids aglycones 
The remained compounds (13 - 25) didn't show any sugar or organic acid residues (Table 
4) and are defined as less polar flavonoids. The unsubstituted flavone (21) and monomethox-
yflavone (22) were the predominant metabolites. The compounds were shown to bear a vary-
ing number of OH and OMe groups. The HRMS data (Appendix 17) obtained for these me-
tabolites were comparable to those reported in literature for the epicuticular flavonoids from 
Primula plants. Furthermore, based on the NMR analysis of the active metabolites discussed 
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in section (4.1.3), compounds 17, 19, and 22 were identified as 2'-hydroxyflavone, 5,6,2',6'-




























5.1. Biological evaluation and active metabolites identification in P. veris 
flowers and P. boveana leaves 
 
Given that Primula plants are known to accumulate versatile metabolites, their biologi-
cal/chemical investigation would provide valuable information for the evidence-based herbal 
medicine. So, in this study, we sought to track the antibacterial and anti-AChE/BChE metab-
olites occurring in the medium polar extracts of two Primula species, P. veris and P. bo-
veana. As a modern streamlined hyphenation with many unparalleled features, HPTLC-EDA 
was sought to study the titled plants. 
The first bioactivity screened was the antibacterial bioassay, in which two bacterial strains, A. 
fischeri (Gram-negative) and B. subtilis (Gram-positive) were used. The results of the 
HPTLC-antibacterial bioassays showed that two bacterial inhibitors existed in the extract of 
P. veris, while four active metabolites were detected in the P. boveana extract. Growth inhi-
                                                                              5. Discussion 
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bition in A. fischeri was observed as dark spots vs. a luminescent background. While in B. 
subtilis, the inhibition was detected as white spot against the purple background due to reduc-









Fig. 30. Reduction of MTT into purple formazan by B. subtilis bacteria 
 
The polarity of the detected active metabolites could be easily anticipated from the used de-
veloping system (hexane : EtOAc, 7:3, V/V), which indicated their lipophilic tendency. The 
direct mass analysis on HPTLC has permitted the assignment of such metabolites, which fur-
ther confirmed by the NMR measurements. 
In P. veris, the two active bands were determined as PUFAs, linoleic (C18:2, Pv1) and 
linolenic acids (C18:3, Pv2). Primulaceae is one of the higher plant families that are known 
to accumulate several PUFAs (Sayanova et al. 1999; Sayanova et al. 2003). Both acids have 
been previously described among the principle fatty acids occurring in P. macrophylla and P. 
macrocalyx (Tsydendambaev et al. 2004; Kosenkova et al. 2008). Production of PUFAs in 
plants has been suggested to correlate with stress exposure, i.e. biotic/abiotic. Alteration of 
the membrane fluidity in stress-resistant plants has been linked to the release of α-linolenic 
acid (Upchurch 2008). Iba (2002) concluded that PUFAs play an important role in plants sur-
vival towards low temperature conditions, basically, through controlling the formation of 
chloroplast membranes. The antibacterial potential of PUFAs, including linoleic and linolenic 
acids, has been covered in earlier reviews (McGaw et al. 2002). The antibacterial activity of 
linoleic acid in Neem oil has recently been reported using direct bioautography (Krüzselyi et 
al. 2016). Chang et al. have studied the mechanism of antibacterial action of linoleic acid 
(Zheng et al. 2005). They concluded that linoleic acid principally targets the fatty acid syn-
thesis in bacteria through inhibition of enoyl-acyl carrier protein reductase, which found to be 
inhibited by some other related compounds like linolenic, palmitoleic acid, and oleic acid. 
Their study also demonstrated the importance of unsaturation and the free acid group of lino-
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leic acid as essential structural components for inhibition of the enoyl-acyl carrier protein re-
ductase. Besides the unsaturation, the chain length was also found as crucial structural feature 
for effectiveness of fatty acid towards inhibition of sporulation in B. subtilis (Strauch et al. 
1992). Extracts of P. veris flowers prepared by three different solvents (ether, ethanol, water) 
showed inhibitory activity with varying degrees against ten types of bacteria with ethanolic 
extract demonstrated a distinct inhibition to Enterococcus faecalis, Bacillus cereus, and 
Pseudomonas fluorescens (Xu and Lee 2001). 
 
With regard to P. boveana, the four detected active metabolites (Pb1 - Pb4) were deter-
mined as lipophilic flavonoids in nature. Their structures were confirmed by means of HRMS 
and NMR analysis as follow: unsubstituted flavone (Pb1), 2'-methoxyflavone (Pb2), 2'-
hydroxyflavone (Pb3), and 5,6,2',6'-tetramethoxyflavone (Pb4). Under the used application 
volumes, all four compounds have successfully inhibited A. fischeri growth, while B. subtilis 
was found sensitive to only Pb1 and Pb2. Lipophilic flavonoids are abundantly produced by 
Primula species and generally referred to epicuticular flavonoids, so to be distinguished from 
the tissue-type flavonoids which in common regarded as more polar metabolites. Primulas 
accumulate epicuticular flavonoids leaded by unsubstituted flavone, which is substituted with 
many OH and/or OMe groups at different positions. The most common sites for these sub-
stituents are 5, 2', and 8 (Colombo et al. 2017). Some compounds are known to be shared by 
several Primula plants, e.g. unsubstituted flavone, 2'-hydroxyflavone, 5-hydroxyflavone, 5,8-
dihydroxyflavone, 2'-methoxyflavone, and 5,2-dihydroxyflavone. These literature findings 
strongly support our results of structural definition of the active metabolites detected in P. 
boveana. In this study, the unsubstituted flavone was the most profound inhibitor as revealed 
by its relevant zone of inhibition. In literature, unsubstituted flavone has displayed inhibitory 
activity against methicillin-resistant Staphylococcus aureus (MRSA) (Xu and Lee 2001). The 
unsubstituted flavone also found as the principle metabolite responsible for the antileishma-
nial and cytotoxic activities of the chloroform-soluble fraction of P. macrophylla (Najmus-
Saqib et al. 2009). In a susceptibility testing, Bakar et al. (2012) have studied the impact of 
combination of nine different flavonoids (including the unsubstituted flavone) with vanco-
mycin or oxacillin against vancomycin-intermediate Staphylococcus aureus. They found that 
only unsubstituted flavone was able to provoke a synergistic effect with both antibiotics, 
while other flavonoids have shown an additive action. Therefore, they concluded that unsub-
stituted flavone is worth to undergo further interaction studies at the molecular level. In an-
other study conducted by Basile et al. (2010) aimed to track the antimicrobial principles in 
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Feijoa sellowiana Berg. fruit extract, unsubstituted flavone was identified as the active me-
tabolite present in the extract. Through their bioactivity-guided study on the fruit extract, un-
substituted flavone has significantly inhibited different types of bacterial strains, including 
Helicobacter pylori, and fungi. These literature reviews regarding the antibacterial attributes 
of unsubstituted flavone would also verify its distinct antibacterial potential discussed in our 
results. 
Flavonoids are a large class of plant secondary metabolites, they occur in almost each organ 
of the plant. They perform several physiological functions in plants; induction of their bio-
synthesis is thought of as one of the defense mechanisms that the plant uses to fight against 
attacking pathogens. This property has been receiving a growing interest for the possible con-
tribution of such naturally abundant chemicals as useful antimicrobial agents in humans 
(Cushnie and Lamb 2005; Jucá et al. 2018). Due to their diverse structural features, these 
compounds show variable physicochemical properties, which usually influence their antimi-
crobial behavior. However, the hydrophobic characteristic was determined as a crucial prop-
erty for the effectiveness of flavonoids as antibacterial (Echeverría et al. 2017), and this could 
indicate that disturbing the bacterial cell membrane rigidity is one of the underlying mecha-
nism of actions of flavonoids (Wu et al. 2013). 
 
The second activity investigated was the AChE/BChE inhibition. So far, the activity of the 
genus Primula as ChE inhibitors has not been very well studied. To our knowledge, in one 
study, P. officinalis (L.) Hill (syn. of P. veris) flowers extract showed a moderate inhibition 
to AChE and BChE (Wszelaki et al. 2010). So, the obtained biological results would provide 
useful information for the use of such plants in treatment of the relevant diseases, e.g. AD 
and Myasthenia gravis. 
The active compounds in the examined extract showed up as white zones against a purple 
background as previously described by Marston et al. (Marston et al. 2002) and based on the 
reaction showed in Fig. 31. 
 
Fig. 31. Enzymatic reaction of AChE and 
BChE on the corresponding substrate with 





     The results of AChE/BChE inhibition assay on P. veris revealed that linoleic and linolenic 
acids were also the main AChE/BChE inhibitors present in the extract. PUFAs are essential 
fatty acids that should be provided to our bodies from external sources, e.g. vegetable oils. In 
brain, PUFAs are essential for a proper neuronal transmission since they generally serve as 
building components of the neurons. Incorporation of PUFAs into neuronal membranes en-
hances the membrane fluidity and integrity; as a result, improve the neurotransmission, which 
is useful in cognitive function (Jicha and Markesbery 2010). Therefore, the beneficial role of 
PUFAs in treatment of neurodegenerative diseases like AD has been reported in some studies 
(Willis et al. 2009; Bentsen 2017). Diets rich in docosahexaenoic acid, a major PUFA, was 
suggested to be helpful in treatment of many neurological disorders, e.g. AD and depression 
(Farooqui and Horrocks 2001). The implication of PUFAs as ChE inhibitors have been also 
established through some studies that used dietary oils contained varying amount of PUFAs 
(Willis et al. 2009). Ren et al. (2006) found that the PUFAs-rich fraction of the centipede 
Scolopendra subspinipes mutilans L. Koch displayed an AChE inhibitory activity. The find-
ing that promoted the authors to investigate the AChE potential of some other related PUFAs 
including linoleic and linolenic acids. Their results concluded that the inhibitory activity is 
linked to some structural prerequisites, a chain length of more than 16 carbon atoms, the 
presence of at least one saturation, and the intact acidic group, are all found essential for exe-
cution of the inhibition action by PUFAs. Moreover, the docosahexaenoic acid was the most 
active among the screened PUFAs, with activity found 200 times as higher as the standard 
reference, physostigmine. However, linoleic acid inhibited AChE in a concentration-
dependent pattern. 
In P. boveana, compounds (Pb1 - Pb4) inhibited BChE, while AChE has been inhibited only 
by Pb1 & Pb2. Flavonoids as omnipotent chemicals have and continue to inspire researchers 
to explore their multiactivities. Flavonoids have been acknowledged as enzyme modulators. 
They could efficiently modulate many phase I and phase II metabolic enzymes (Miron et al. 
2017); they showed inhibitory activity towards many enzymes related to several pathogenesis 
(Guerrero et al. 2012). As a part from the well-known AChE/BChE inhibitors from alkaloid 
origin, flavonoids have recently emerged as a new class of compounds capable of inactivat-
ing this group of enzymes (Uriarte-Pueyo and Calvo 2011). Inhibition of AChE/BChE is 
linked to the treatment of many neurodegenerative diseases, in particular, AD (Khan et al. 
2018). This enzyme inhibitory capability along with some other bioactivities like anti-
amyloidogenic, anti-oxidant, and anti-inflammatory properties have strongly promoted the 
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use of flavonoids as comparably safe candidates for prevention and/or symptomatic relief of 
AD (Baptista et al. 2014; Bakhtiari et al. 2017). 
The AChE-inhibitors interactions at the molecular level have been discussed by Roseiro et al. 
(2012). The peripheral anionic site at the entrance point of the active site gorge of the enzyme 
was suggested to be the position at which the inhibitors usually affect modulation of the en-
zyme. Moreover, the pattern that flavonoids usually orient themselves inside the AChE gorge 
active site was found similar to that usually adopted by the known inhibitor, donepezil. 
Apparently, unsubstituted flavone (Pb1) was found as a potent antibacterial and AChE/BChE 
inhibitor. So an attempt to evaluate its AChE inhibitory potency compared to the well-known 
standard inhibitor, Riv, was carried out through the AChE inhibition equivalency study. The 
results were very encouraging, as the inhibitory activity exerted by Pb1 in the P. boveana 
extract was found half as strong as of Riv. This result paves the way for further studies con-
sidering the possible implementation of unsubstituted flavone in treatment of the relevant 
diseases such as AD. The compound is ubiquitous in nature and considered as comparably 
safe and cheap chemical when compared to other drugs used in this regard. 
 
In conclusion, this part of the study was designed with the purpose of searching for poten-
tial inhibitors to bacteria and AChE/BChE from natural sources. For many reasons, an inter-
est in shifting to natural counterparts has attracted many researchers. Some of these reasons 
could be explained by the big worry surrounding the rapid bacterial resistance to the available 
antibiotics, the significantly growing number of people diagnosed with AD, the adverse ef-
fects associated with the administered synthetic drugs. Our results have determined the major 
active metabolites in both bioassays as being belonging to rather ubiquitous natural products. 
However, our study possesses the novelty with regard to some aspects:  
• The type of the plant species as demonstrated by P. boveana, which has not been pre-
viously evaluated for its biological activity. 
• The type of bioactivity screened or the microorganism used: as the current study is 
considered as the first report dealing with targeted tracking of the AChE/BChE inhibi-
tors in both species. 
• The bioactivity information collected: as clearly indicated by the multibioactivities of 
unsubstituted flavone, 2'-methoxthyflavone. 
• The bioanalytical technique used for EDA of the studied extracts. 
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5.2. Biological evaluation and active metabolites identification in A. pu-
bescens 
 
In the second part of the PhD study, we aimed to investigate the hydro-alcoholic extract 
of A. pubescens for the presence of active AChE inhibitors. The part is distinguished from the 
former section in using a different botanical species that is known to produce a different 
group of secondary metabolites in its tissue. Thus, providing wider insights with regard to the 
ChE inhibitory activity of diverse groups of natural products that are not related to alkaloids. 
Bioactivity-guided screening of the plant extract has been also accomplished through the 
HPTLC-EDA procedures. The HPTLC-AChE inhibition assay led to identification of three 
inhibitors, two of which are here described as newly isolated natural compounds. The active 
metabolites were determined as derivatives of antirrhinoside iridoids and there structures 
were identified as follow: 6-O-, 6'-O-di-trans-cinnamoyl-antirrhinoside (A1), 6-O-
foliamenthoyl-(6ꞌ-O-cinnamoyl)-antirrhinoside (A2) and 5-O-, 6-O-difoliamenthoyl-
antirrhinoside (A3). The structures of the new metabolites (A1 & A3) were determined based 
on extensive analysis of their NMR and MS spectroscopic data. Whereas, the structure of A2 
was furnished by interpretation of its HRMS and HRMS2 spectrometric data. 
A. pubescens belongs to family Plantaginaceae, which is known to harbor species producing 
diverse chemical phyto-constituents. Iridoids are one of the major secondary metabolites pro-
duced by Plantaginaceae plants. Plants of the genus Anarrhinum also reported to accumulate 
iridoid glycosides in their arial parts. The iridoid glycosides described so far in the genus are 
derived primarily from antirrhinoside or mussaenosidic acid (Dawidar et al. 1989; Salah El 
Dine et al. 2011; Mahran et al. 2018) with the former is being esterified with cinnamic and/or 
foliamenthoic acids, hence, substantiate our structures assumption for the active metabolites. 
Iridoids demonstrated important biological functions resulting from their inhibitory actions 
on many biological enzymes. The antitumor activity of aucubin and geniposide have been 
also proposed to be due to their potent inhibition to topoisomerase I, leading to DNA damage 
(Gálvez et al. 2005). Also, several iridoids from plants that are known in Mexico for their 
ethnomedical value as anti-inflammatory have been tested by Ramírez-Cisneros et al. (2015) 
against cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes; loganic acid 
was found the most active compound. With regard to AChE, iridoids have been also reported 
to inhibit such enzyme. Loganin obtained from the fruits of Cornus officinalis inhibited 
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AChE in hippocampus of mice by as much as 45% compared to control groups (Lee et al. 
2009). Likewise, E-harpagoside and 8-O-E-p-methoxycinnamoylharpagide isolated from 
Scrophularia buergeriana exhibited AChE inhibition activity to a level similar to that ob-
served with donepezil; this characteristic potential was suggested to be the reason behind the 
cognitive function improvement in mice (Jeong et al. 2008). Moreover, iridoid compounds 
isolated of Patrinia scabiosaefolia showed inhibition to AChE (Liu et al. 2017). Catalpol, an 
iridoid with a structure that is very similar to antirrhinoside, also proposed to have AChE in-
hibitory activity (Zhang et al. 2013). In view of the foregoing enzymes modulating activities 
of iridoids, our AChE inhibitory findings deemed to be warranted. 
What is more in our study is that it reports, for the first time, the AChE inhibitory potential of 
antirrhinoside-derived iridoids and further delivering some structure activity relationships as 
deduced from the AChE inhibition equivalency study performed at a fixed applied amount 
(20 µg/band). The results revealed that compound A3 at this concentration showed peaks area 
that seems to be below the detection limit. Compound A3 differs from A1 & A2 in that it has 
the 5-OH position esterified with another foliamenthoyl unit. Even though replacement of the 
cinnamoyl moiety (compound A1) by this structural unit increased activity of compound A2 
by approximately 4 times. In contrast, esterification of 5-OH with a second monoterpene 
moiety has dramatically lowered the activity, meaning that the free 5-OH is essential to main-
tain the AChE inhibition of antirrhinosides derivatives. 
 
In summary, the second part of this PhD study described the isolation of three AChE in-
hibitors from A. pubescens extract, with two of these metabolites are considered as precedent-
ly not reported natural products. The study therefore integrates and verifies several previous 
reports proposing the beneficial neuroprotective role of iridoids and their promising roles in 
treatment of many related diseases in particular AD. It is worth to mention that AChE inhibi-
tion is currently the main therapy available for alleviating AD. It also details the structure 
elucidation of the known metabolite (A2) based on its tandem mass data, thus, would be of a 
privilege as a reference for any upcoming researches dealing with chemical profiling of the 







5.3. HPTLC-GUS inhibition assay hyphenation 
 
This experiment shapes the third part of the current PhD study. The overall object was to 
integrate the HPTLC to GUS inhibition assay as a new hyphenation technique in an effort to 
rapidly refer to the individual GUS inhibitory activity of each component in complex matri-
ces. 
Glucuronidation is a principle phase II process through which the body gets rid of many 
harmful xenobiotics. However, the reverse reaction could happen and leads to release of the 
active parent compounds, causing their re-absorption into the body through the intestinal lu-
men. This retrograded process is a deglucuronidation reaction; mediated through GUS of the 
gut bacteria (Cheng et al. 2015). Prolonged exposure of the body to these harmful xenobiot-
ics evidently established as a predisposing factor for several pathological events such as in-
testinal injuries and various types of cancer. Hydrolysis of the glucuronide-conjugates of 
many important drugs by GUS of bacteria housed the gastrointestinal tract have been report-
ed, e.g. Irinotecan and NSAID (LoGuidice et al. 2012). 
While these examples represent medicinal candidates, microbial GUS has been evidenced to 
aggravate the deleterious effects of some food products including heterocyclic amines. Het-
erocyclic amines are food-borne carcinogens that are excreted from body via phase II glucu-
ronidation process, e.g. 2-amino-3-methylimidazo[4,5-f]quinoline; however, in the intestine, 
microbial GUS hydrolyses the conjugated products, and thus enhancing their genotoxicity 
(Carmody and Turnbaugh 2014). 
Collecting together the aforementioned harmful consequences traced to the hydrolytic activi-
ty of microbial GUS on xenobiotics-glucuronide conjugates, several studies have been focus-
ing on developing drug candidates targeting such enzyme inhibition. For the purpose of de-
tecting and evaluating the GUS inhibitors, many conventional methods are available. Never-
theless, these methods could only evaluate the GUS inhibitory activity of the total mixture, 
e.g. plant extract without giving any definite information about the activity of the individual 
compounds unless they are further separated. Therefore, samples pretreatment is necessary, 
rendering these methods rather tedious and time/material consuming interventions. The reac-
tion in general is carried out in Eppendorf or in well plates followed by spectrophotometric 
measurements at a selected wavelength. Hence, imparting other limitations to these methods 
such as difficulty in dissolving lipophilic compounds in a solvent that is compatible with the 
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aqueous enzyme solution, and the possible interference from the dissolving solvents either on 
the enzyme activity or the results readout. 
In view of the above stated challenges, it would be worthwhile developing a new method for 
detection of GUS inhibitors in complex mixtures. In this part of the study, we successfully 
linked the HPTLC to the GUS inhibition assay. Thus, allowing efficient chromatographic 
separation of the mixture components followed by in situ assay application on the developed 
autograms. 
The detection method used in this study depended on the enzymatic reaction previously de-













Fig. 32. GUS enzymatic reaction using X-Gluc as a substrate. 
 
The active inhibitors shown up as white spots against a blue background, permitting their 
colorimetric detection. Given that fluorescent intermediates are formed during the enzymatic 
reaction, fluorometric detection is also feasible. So, the method could provide two methods 
of detection. Ramallo et al. (2015) has reported a dual readout assay for detection of AChE 
inhibitors using indoxyl acetate as a substrate, which is closely related to X-Gluc and liberate 
colorless fluorescent intermediates, as well. It is noteworthy to mention that X-Gluc is gener-
ally regarded as chromogenic as well as fluorogenic substrate for GUS and routinely used as 
a histochemical reagent (Jefferson 1987; Frampton et al. 1988). However, while developing 
this method, we devoted more focus to the colorimetric detection as being the prevalent ap-
proach in most of the HPTLC-EDA protocols; it also doesn't need any sophisticated instru-
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mentations for documentation since the active inhibitor are easily observable under white 
light. 
 
In order to bring our method to the up-to-date means of HPTLC derivatization, all applied 
solutions (enzyme and substrate) were delivered to the HPLTC via the piezoelectric spraying 
technology using the TLC derivatizer (Azadniya and Morlock 2019). This recently intro-
duced technology to the field of planar chromatography carries several advantages over the 
classically used automated immersion technique. The new micro droplet spraying technology 
ensures the homogenous transfer of all solutions to the plate; it allows chemical/material 
worry-free workflow, as it doesn't need large amounts of solutions. Typically in our method, 
3.0 mL was the maximum used volume to spray a plate of 10 x 20 cm. while, in automated 
dipping, approximately 100 mL solution is needed for a plate of the same area; this is consid-
ered a major obstacle enzymatic assays which in general seen as expensive material. One 
such superiority for using the piezoelectric derivatization is that studied plates are sprayed 
while horizontally positioned, thus, avoiding a shift of the inhibitory bands and ensures a 
good resolution of adjacent compounds. 
 
The method has been optimized with respect to the detection wavelength, enzyme con-
centration, reaction time, and the effect of using HPTLC plates with and without fluorescent 
indicator. For all of these parameters, the reaction temperature was kept at 37 ºC and pH 7.0 
which repeatedly used working conditions in GUS assay (Jefferson 1987; Sekikawa et al. 
2002). Also, SL was used as a standard inhibitor and the collected peak areas of the inhibi-
tion zones were used as a criterion for optimization experiments. 
 
The optimum wavelength for colorimetric detection was found between 610 - 650 nm as de-
duced from the UV-Vis absorption spectrum for the background acquired at 200 - 800 nm. 
This range is acceptable for visible detection range of the blue indigo, which showed absorp-
tion maximum at 610 nm (Seixas de Melo et al. 2004). It is well known that indigo deriva-
tives experience another absorption maxima in the UV range, which probably explains the 
observed absorption peaks at 306 nm. The optimum GUS concentration was determined as 
25 U/mL (3.0 mL used for each run). In view of the conventional assays, Sekikawa et al. 
(2002) used 5 U of GUS from E. coli per reaction mixture, while Karak et al. (2017) used 
98.6 U of bovine liver GUS for every reaction mixture. Accordingly, our developed method 
has significantly lowered the amount of the enzyme used. With regard to the reaction time, 
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60 min incubation after substrate application was found superior to 20 and 40 min as re-
vealed from the statistical analysis of the collected data for peak areas of inhibition. Another 
attempt was made to inspect a longer reaction time at 2 h. The statistical analysis showed a 
significant difference between 1 & 2 h reaction times, indicating that 2 h is better. However, 
that would be at the expenses of the whole experiment time. So, 1 h reaction time was found 
as entirely reasonable for the developed method. In classical procedures of GUS assay using 
p-nitrophenyl-β-D-glucuronide as a substrate, the reaction is usually terminated by addition 
of alkali after varied reaction times, but commonly from 50 - 60 min (Karak et al. 2017; Kim 
et al. 1999). The influence of fluorescent indicator on the colorimetric as well as fluorometric 
detection of the developed method was also studied using two types of HPTLC of plates, i.e. 
with and without fluorescent indicator. The results showed a significant difference between 
the plate types under both detection methods; fluorescent HPTLC plates yield better peak ar-
eas. Meaning, for the current assay, HPTLC plates with fluorescent indicator are preferred. 
The method has been validated in terms of LOD, linearity, and specificity. A range of SL 
concentrations have been applied such that we can determine the lowest concentration that 
could be detected with S/N ≥ 3. In our method the lowest concentration applied and provided 
S/N = 4 was 62 ng/band. The method showed also a linear regression within the range of 62 - 
1000 ng/band that fits to a second order polynomial equation. The specificity of the estab-
lished method has been also confirmed using different substrate, which demonstrated no re-
sults, i.e. background acquired no color. 
 
Up to this point, an optimized hyphenation protocol for linking the GUS inhibition assay 
to HPTLC has been efficiently established and validated to some terms using a standard ref-
erence inhibitor (SL) that was applied directly without chromatographic development. So, a 
verification study was performed to evaluate the capacity of the newly developed protocol to 
detect the active inhibitors present in a complex mixture after being chromatographed. 
Thereof, two representatives of botanical material were used, P. boveana and SFLG. Both 
plant materials were selected with the view of their chemical constituents. Also, a particular 
attention was given to investigate the compatibility of the developed workflow with different 
developing systems composed of some commonly used solvents and the impact of including 
an acid as a modifier. 
In P. boveana, the non-polar metabolites (Pb1 & Pb2) developed with hexane : EtOAc 
(7:3, V/V) have been readily detected without prior neutralization of the plates. Flavonoids 
are prevalent bioactive compounds. They demonstrated inhibitory activity against many en-
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zymes, nonetheless, few is known regarding their GUS inhibitory properties. In a previous 
study, Weng et al. (2017) have evaluated the inhibition activity of 30 flavonoids against E. 
coli GUS with additional structure activity relationship analysis. Their results showed that 
flavones without glucosyl or methoxyl modification displayed strong inhibitory effects 
against E. coli GUS with two flavonoids, scutellarein and luteolin, were found the most po-
tent inhibitors and activity described as higher than the standard inhibitor, SL. 
 
The second botanical model studied was SFLG. Silymarin is a collective term for flavo-
nolignan constituents in Silybum marianum, Asteraceae (milk thistle). The extract of the 
plant has a wide scope of therapeutic applications. While, the antioxidant, anti-inflammatory, 
and chemopreventive activities have been proved for plant extract (Katiyar 2005); hitherto, 
the most known from literature and evidently established is its beneficial roles in hepatic dis-
orders including, hepatitis, cirrhosis and fibrosis (Abenavoli et al. 2010; Csupor et al. 2016). 
One major compound was observed in the SFLG extract after application of the optimized 
assay and marked as SFLG1. The influence of using different MP composed of various sol-
vents and with varying FA proportions was also studied. The plates were studied with and 
without prior neutralization as well. With MP1 (8.5 % FA), the assay didn't work at all unless 
the plates were neutralized in advance. In contrast, with MP2 (2.6 % FA) the assay is still 
able to provide the inhibition information. 
Many active metabolites reside in the polar fraction of plant extract and, in many cases, the 
use of acidic MP is practically indispensible for their separation. Acidic MP is a serious im-
pediment for microbiological or enzymatic assays being hyphenated with planar chromatog-
raphy. The acid is retained on the plate and difficult to remove with the conventional meth-
ods of drying, e.g. using hair dryer, thus, impair the applied (bio)assay. In accordance, neu-
tralization of the developed chromatogram was found as a determinant intervention for ac-
complishment of the assay. Jamshidi-Aidji and Morlock (2015) have discussed several meth-
ods of neutralization for plates being developed in acid-containing MP. They concluded that 
a buffer, in their case citric acid-phosphate (0.2 M) at pH 7.8, worked efficiently and retained 
the optimum pH of the plate at 7 ± 0.2 to accommodate the applied microbial and enzymatic 
(bio)assay. Similarly, Hage and Morlock (2017) implied the neutralization step for bioprofil-
ing of Salicaceae bud extracts and, for this, they immersed the plates into 2% sodium hydrox-
ide solution. Thus, as clearly observed in both plant samples used, the current assay can tol-
erate FA inclusion up to certain proportions under which it can work to some degrees. The 
maximum that the current assay can tolerate has not attempted and could be the objective of 
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further studies. Nevertheless, our visual observation of the results favors the application of 
neutralization step if acidic MPs are to be used. 
The extensive mass spectrometric analysis represented by HRMS and HRMS2 measure-
ments together with the help of the literature comparison (Brinda et al. 2012; Kuki et al. 
2012a, 2012b) have fundamentally assisted in structure identification of this metabolite as 
silychristin. Basically, silymarin contains two silychristin diastereomers A & B and it was 
not possible to be distinguished from their MS data primarily, because of their comparable 
mass fragmentation pattern (Shibano et al. 2007), thus, herein collectively named as si-
lychristin. The mass spectrometry has been extensively used to characterize the major con-
stituents of silymarin, and it is well defined that the fragmentation behavior of such compo-
nents is energy-dependent. Therefore, a range of collision energies (10 - 50 V) was applied 
and the occurrence as well as relative abundance of the diagnostic peaks was used for identi-
fication of the active metabolite. The optimal CE was found as 20 V, which is in accordance 
with the previously set values. To date, only single study have coupled the HPTLC to 
(bio)assays and mass spectrometry for profiling of the active metabolites in milk thistle 
(Taha et al. 2015); the authors have only identified the active metabolite in the extract as si-
lybin through the low resolution MS analysis and comparison with standard. So, our current 
findings considered as the first report for linking HPTLC to HRMS/tandem HRMS for analy-
sis of silymarin. 
Silymarin as an inhibitor to GUS has been previously studied. Kim et al. (1994) have evalu-
ated the GUS inhibition potential of three metabolites isolated form silymarin (silybin was 
one of them) and concluded that silybin considerably inhibited the enzyme. The hepatopro-
tective outcomes as a result of the GUS inhibition has been proposed through establishment 
of such activity in plants used to treat liver disorders (Karak et al. (2017). A strong clue of 
the hepatoprotective potential of GUS inhibitors has been also determined for lactic acid bac-
teria, which significantly inhibited GUS of intestinal microflora (Han et al. 2005). 
So, the selection of the plant for the verification study seems meaningful and the results 
would promote our knowledge with respect to the evaluation of the individual GUS inhibito-
ry potential of this medicinally important plant. Besides, the results could offer a piece of ev-
idence to support hepatoprotective characteristics of the GUS inhibitors. A part from the 
HPTLC-GUS assay findings, the MS analysis of silychristin and the fragmentation behavior 




In conclusion, this part of the study describes for the first time an efficient, optimized pro-
tocol for linking planar chromatography to in situ evaluation of GUS inhibitory activity. By 
means of this new hyphenation, sample mixtures can be evaluated in parallel for the presence 
of the enzyme inhibitors. It provides the possibility of dual output of the results (colorimetric 
and fluorometric). A number of concerned aspects have been addressed and discussed during 
the method verification like using different MPs, impact of FA as a modifier at different per-
centages, and important mass interpretation of the active metabolites. 
 
5.4. HPLC-HRMS and EPI analysis for identification of flavonoids consti-
tutes in P. boveana leaves 
 
P. boveana is a wild plant growing endemically in mountainous Saint Catherine region in 
Egypt. P. boveana is the only species representing the genus Primula in Egypt (El-Karemy 
and Hosni 1993). According to the 2014 IUCN report, the total number of the mature indi-
viduals was estimated as less as 165 (IUCN 2014). The report indicated that several impacts 
generally attribute to the remarkable reduction in the population of the titled plant; with the 
climate changes, marked by long drought periods, were impacting the most. In general con-
sensus, synthesis and biogenesis of secondary metabolites in plants depend on numerous fac-
tors and greatly influenced as the plants are exposed to imminent stresses/threats. Verma and 
Shukla (2015) have reviewed the importance of the environmental factors, biotic and abiotic, 
as key players on the production of secondary metabolites in plants. Considering its critically 
endangered status and the pressing exogenous factors, P. boveana is worth chemically inves-
tigating with the purpose of possible revealing a plant-specific chemical profile. 
 
As a time and material saving method, LC coupled to mass analysis was preferred to study P. 
boveana (80% methanol extract). Following the LC-MS protocol mentioned in the method-
ology section (3.6), a total of 25 flavonoid compounds have been tentatively identified. The 
LC-HRMS analysis suggested the elemental composition for each resolved peak with mass 
errors of less than 0.7 ppm, and then the tentative structures were assigned based on the 
fragmentation pattern affected by CID MS/MS. The characterized metabolites represented 
varied structures of flavonoid aglycones as well as glycosyl conjugates. Thirteen of these me-
tabolites were defined as glycoconjugated flavonoids with three of them showed an addition-
al acylation with malonyl unit. The characteristic loss of 86 Da in EPI measurement unam-
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biguously indicated the presence of such malonyl group. These three metabolites have been 
tentatively assigned as: two isomers of dihydroxyflavone-O-malonylhexoside (11, Rt 26.7 
min & 13, 27.5 min) and flavone-O-malonylhexoside (12, Rt 27.4 min). Transfer of the mal-
onyl moiety to flavonoid molecules is basically catalyzed by the action of malonyltransferase 
and preferably linked to the OH of the sugar residue (Kogawa et al. 2007). In general, malo-
nylated flavonoids glycoconjugates show broad structure variations in terms of attachment 
position of the malonyl group on the glycone part (Muth et al. 2008). Malonylated flavones 
and flavonols have been previously reported, however, in genus Primula the occurrence of 
such compounds was not reported in literature. One more structure (9, Rt 25.5 min) that seen 
distinct to the studied plant species and, to our knowledge, previously not described to any of 
the Primula species. The simplicity of the MS data of 9 has largely helped to confirm its 
structure as flavone-O-hexoside. The compound showed a transition from m/z 401 to m/z 
239, suggesting a loss of one hexoside unit with the remaining flavonoid aglycone assigned 
as monohydroxy flavone. Whereas, the exact position of the OH group on the aglycone moie-
ty was not determined, it might be centered at the C-2' as formerly found in section (4.1.3). 
Noteworthy, several flavone-O-hexoside structures have been reported in literature, e.g. fla-
vone-3-O-glucoside (Thirugnanasambantham et al. 1990; Miyakoshi et al. 2010), flavone-6-
O-glucoside and flavone-7-O-glucoside. The above-discussed metabolites are considered 
species-specific and importantly distinguish P. boveana from other Primula species. The rest 
of the glycoconjugated metabolites were dominated by two different aglycones, kaempferol 
and quercetin, that being glycosylated by either di- or tri-saccharides. The consecutive loss of 
the sugar in the EPI spectra has determined the building unites of the glycone units. The fact 
that Primula plants are capable of producing wide range of flavonoids that are glycosylated 
with different mono saccharides (glucopyranoside, galactopyranoside, and rhamnopyra-
noside), disaccharides (rutinoside, gentiobioside, robinobioside, neohesperidoside, and 
sophoroside), and tri-saccharides has made the definite assignment of the metabolites de-
pending only on MS analysis a considerable challenge. 
 
Beside the glycoconjugated flavonoids, 12 more compounds were identified as free flavonoid 
aglycones. Initial attempts were made to collect the EPIMS data for their protonated ion 
peaks but the results were not enough informative. So, their identification was chiefly based 
on their HRMS data, compounds determined in section 4.1.3, and the literature reviews. Un-
substituted flavone and 2'-methoxyflavone dominated the identified compounds. Primulas are 
well known to accumulate diverse lipophilic flavonoids leaded in principle by the unsubsti-
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tuted flavone. The lipophilic flavonoids that frequently occur in Primula have some structur-
al peculiarities as they show hydroxylation and/or methoxylation at unusual positions within 
the flavone molecule (Bhutia and Valant-Vetschera 2012). These free flavonoid aglycones 
are generally termed as epicuticular flavonoids as they always deposit on the outer surfaces 
of arial parts of the plant, with many relevant protection as well as adaptation functions 
(Cuadra and Harborne 1996; Isshiki et al. 2014). As a result of their unusual structural pat-
tern, their underlying a biosynthetic pathway is rather confusing and it is assumed that these 
compounds are biosynthesized from still unknown pathway (Elser et al. 2016). 
 
In conclusion, the HPLC-HRMS and EPI-MS/MS analyses have proven their capability 
to provide valuable structural information for constituents of a complex mixture. The initial 
assumption, that the tough growing conditions and the pressing environmental impacts on P. 
boveana could impose unique chemical features to the plant, has been gotten to the point. 
While the titled plant displays chemical profile that partially in harmony with this previously 
reported for many other Primula sp., it is still reserving a particular capacity to accumulate 
other new metabolites. These new structural findings (represented by compounds 9, 11-13) 
and their occurrence could be explained as a kind of the survival or adaptation mechanisms 



















The aimed at the biological and chemical investigations of two plant species, P. boveana, 
and A. pubescens that endemically grow in St. Catherine, Egypt, along with the well-known 
medicinally important species, P. veris. Considering the scarce nature of the endemic species, 
biological-chemical hyphenated systems were found the most suitable for their analysis. 
Therefore, the study involved:  
1) Guided isolation of the bacterial and/or ChE inhibitors from P. boveana, P. veris, and 
A. pubescens by means of HPTLC-EDA-HRMS technique.  
2) Development of a new HPTLC-GUS inhibition assay hyphenation.  
3) Utilization of HPLC-HRMS and tandem MS for flavonoids profiling in P. boveana. 
 
For the Primula sp., the bacterial and AChE/BChE inhibitory activities of their medium polar 
extracts were evaluated. The two species are here studied for the first time using HPTLC-
EDA-HRMS hyphenation. The results revealed the presence of two major active metabolites 
in P. veris, which clearly inhibited the tested bacteria (A. fischeri and B. subtilis) and ChE 
(AChE and BChE). HPTLC-HRMS allowed their structure characterization as linoleic and 
linolenic acids. While in P. boveana, four metabolites have been detected and variably 
showed bacterial and/or ChE inhibition. After isolation of these four metabolites, they were 
structurally identified by means of 1H NMR analysis. Two of them (unsubstituted flavone 
and 2'-methoxy flavone) have inhibited both bacteria tested (A. fischeri and B. subtilis) as 
well as AChE and BChE. While the other two (2'-hydroxy- and 5,6,2',6'-
tetramethoxyflavone) displayed inhibition to only A. fischeri bacteria and BChE. These bio-
activity findings evidenced the multipotent properties of some naturally occurring com-
pounds. Furthermore, HPTLC-AChE inhibition equivalency study on the unsubstituted fla-
vone, as a principle inhibitor, was carried out; it revealed that the unsubstituted flavone as 
exists in 10 µg dry powder of P. boveana inhibited AChE equivalently to 4.5 µg the stand-
ards inhibitor, Riv.     
 
With regard to A. pubescens, HPTLC-AChE inhibition assay led to characterization of 
three inhibitors from the 80% methanolic extract of the plant. The metabolites were assigned 
as antirrhinoside-derived iridoid glucosides. Whereas the AChE inhibitors of many iridoids 
have been previously reported, this study describes for the first time the AChE inhibitory ac-
tivity of the antirrhinoside class of iridoids. Based on the extensive spectroscopic analysis, 
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two of the identified metabolites are here described as newly isolated natural compounds and 
their structures were determined as 6-O-, 6'-O-di-trans-cinnamoyl-antirrhinoside and 5-O-, 6-
O-difoliamenthoyl-antirrhinoside while, the third compound was identified as 6-O-
foliamenthoyl-(6ꞌ-O-cinnamoyl)-antirrhinoside, which is a previously known compound. The 
AChE inhibition equivalency study performed on the isolated metabolites revealed that 6-O-
foliamenthoyl-(6ꞌ-O-cinnamoyl)-antirrhinoside is the most active amongst the three com-
pounds and the free 5-OH is essential to maintain higher AChE inhibitory activity of antirrhi-
nosides derivatives.  
The second part of the study reports the hyphenation of GUS inhibition assay to HPTLC 
for a streamlined detection of the enzyme inhibitors in complex mixtures. The classical 
methods are usually performed on the total mixtures or extracts without pointing to the activi-
ty of the individual components unless being separated in advance, which is seen as a major 
concern as it requires more time as well as material. So, with the newly developed hyphena-
tion, the GUS inhibition activity of each component of the mixture could be in situ evaluated 
after being resolved on the HPTLC. Thus, offers a time/material effective method of biologi-
cal analysis. The detection reaction of the method relied on the enzymatic cleavage of the 
substrate, X-Gluc, followed by oxidative dimerization to give the indigo blue as the final 
product. GUS inhibitors were shown up as white zones against the blue background. In addi-
tion, a fluorescent detection of the inhibition zones is also possible due to the highly fluores-
cent intermediates. Thus, the utilized reaction presents a dual readout of the results, putting it 
steps superior to other commonly used reactions. The optimum wavelength of colorimetric 
detection (610 - 650 nm), enzyme concentration (25 U/mL, i.e. 0.375 U/cm2), reaction time 
(60 min), and plate type (with fluorescent indicator) were all assessed and discussed in the 
view of the literature data. In our method the lowest concentration applied and provided S/N 
≥ 3 was 62 ng/band with S/N of 4. The method showed a good linearity and specificity. Fur-
thermore, the newly developed hyphenation was verified through application on two plant 
extracts, P. boveana and SFLG. The optimized protocol proved its efficiency to detect the 
GUS inhibitors in complex mixtures being separated under different chromatographic sys-
tems, advanced our understanding of the appropriate MP used, and how to overcome the in-
evitable loss of the enzymatic reaction when an acid is used as a modifier. With the help of 
HPTLC-HRMS/MS, the structures of the active GUS inhibitors were assigned.  
Finally, the third part of the study addressed the HPLC-HRMS and EPIMS-based charac-
terization of flavonoids in P. boveana extract. Primula plants are known to accumulate di-
verse scaffolds of flavonoid structures. Nevertheless, the chemical analysis of P. boveana has 
 
	 85	
not thoroughly reported. The elemental composition and the CID MS/MS measurements 
permitted tentative assignment of 25 compounds in total. Thirteen of these metabolites were 
defined as glycoconjugated flavonoids with three of them have shown an additional acylation 
with a malonyl unit, so far, no previous reports on the occurrence of the malonylated flavo-
noids in any plants of the genus is available. Also, flavone-O-hexoside has never been de-
scribed in any species of the genus. The rest of the metabolites (12 compounds) are defined 
based on their accurate mass analysis and determined as epicuticular flavonoids, i.e. produced 
on the outer surfaces of the arial parts of the plant. These were flavonoid aglycones showing 
different degrees of hydroxylation and/or methoxylation. Obviously, P. boveana displayed 
some phyto-constituent particularities, which expressed more in the glycoconjugated metabo-
lites and these chemical profiling, could correlate to the survival and/or defense mechanisms 
that the plant uses to tolerate the stressing influences. 
To summarize, the presented study has revealed many unprecedentedly reported biologi-
cal as well as chemical findings. It supported the evidence-based herbal medicine approach 
for treatment of many major human diseases like infection and AD. The study not only con-
sidered as a proof of principle for the potential of the previously developed HPTLC-EDA hy-
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Appendix 9.  1H NMR spectrum (500 MHz) of compound 3 (in CD3OD) 
	
	















































































































































































Appendix 17. (Continued) ESIHRMS spectra for the flavonoids identified in hydro-alcoholic extract 
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Appendix 18. EPI mass spectra (CE 10 V) of glycoconjugated flavonoids identified in hydro alcohol-





































Appendix 18. (Continue) EPI mass spectra (CE 10 V) of glycoconjugated flavonoids identi-
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10/2010 – 12/2013 M.Sc., Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. 
09/2010 – 06/2011 Advanced graduate courses, Mass and NMR spectroscopic methods. 
Chemistry of natural products.  
09/2009 – 06/2010 Advanced graduate courses, Basics of Organic chemistry, Analytical 
chemistry, Physical chemistry and Mathematics 
09/2001 – 05/2006 B.Sc., Pharmaceutical Sciences, Faculty of Pharmacy, Al-Azhar Univer-




Conferences and workshops 
• Poster, June 2019: "67th ASMS Conference on Mass Spectrometry and Allied Topics", 
Atlanta, GA, USA 
• Oral presentation, June 2019: "48th International Symposium on High-Performance 
Liquid Phase Separations and Related Techniques", Milan, Italy 
• Oral presentation, November 2018: "24th International Symposium for High-Performance 
Thin-Layer Chromatography" Bangkok, Thailand 
• Workshop, October 2018: "Scifinder on campus".  Philipps University of Marburg, 
Germany 
• Conference attendance, August 2017 "Engineering of Functional Interfaces" Marburg, 
Germany 
• Poster, April 2016: "New Iridoid Glycosides from Anarrhinum pubescens". 57th 
Experimental Nuclear Magnetic Resonance Conference (ENC), Pittsburg, PA, USA 
• Poster, January 2016: "In vitro Propagation, Callus Induction and Genetic Fidelity 
Assessment of Anarrhinum pubescens". SC EPSCoR/IDeA State Conference, Columbia, 
SC, USA 
• Workshop, October 2018 "publishing a world class scientific paper". Justus Liebig 
University. Giessen, Germany 
• A member of the Organizing Committee of Al-Azhar international conference for 
Pharmaceutical and Biological sciences 
• Personal and communication skills Courses at NOVARTIS pharmaceutical company 
 
Publications 
• Abdelsalam A, Mahran E, Chowdhury K, Boroujerdi A, El-Bakry A (2017) NMR-based 
metabolomic analysis of wild, greenhouse, and in vitro regenerated shoots of Cymbopo-
gon schoenanthus. subsp. proximus with GC–MS assessment of proximadiol. Physiolo-
gy and Molecular Biology of Plants 23:369-383. 
• Mahran E, Hosny M, El-hela A, Boroujerdi A (2018) New iridoid glycosides from Anarrh-
inum pubescens. Natural Product Reseach 33:3057–3064. 
• Mahran E, Elgamal I, Keusgen M, Morlock G (2019) Effect-directed analysis by high per-
formance thin layer chromatography for bioactive metabolites tracking in Primula veris 
flower and Primula boveana leaf extracts (Journal of Chromatography A, Accepted, in 
print). 
• Mahran E, Morlock G, Keusgen M (2019) Guided isolation of new iridoid glucosides from 
Anarrhinum pubescens by high performance thin layer chromatography-
acetylcholinesterase assay. (Journal of Chromatography A, Accepted, in print). 
• Mahran E, Keusgen M, Morlock G. New planar assay for a streamlined detection and 









Awards and memberships 
• Marburg International Doctorate award: The award involves travelling allowance and 
accommodation expenses for poster presentation at the "67th ASMS Conference on 
Mass Spectrometry and Allied Topics" Atlanta, GA, USA,(2019). 
• Merck group award: The award involves the registration fees to give an oral presenta-
tion at the "48th International Symposium on High-Performance Liquid Phase Separa-
tions and Related Techniques" Milan, Italy,(2019). 
• Yousef Jameel academic foundation award: PhD scholarship in Philipps University of 
Marburg, Germany (2016 - present). 
• Egyptian Pharmacists Syndicate award for scientific excellence performance during 
Faculty years (2006). 
• Cairo Pharmacists Syndicate award for scientific outstanding performance during 
Faculty years, Egypt, (2006). 
• Sharkia Governorate Teaching Professions Syndicate for outstanding performance 
during Faculty years, Egypt,(2006). 
Language Skills 
Arabic: Native, English: Very Good, German: Understanding 
	
